Hormonal Control of Insulin-Like Growth Factor Binding-Protein mRNA Expression in Bovine Granulosa and Theca Cells: Quantification by Realtime RT-PCR by Voge, Justin L.
HORMONAL CONTROL OF INSULIN-LIKE GROWTH
FACTOR BINDING-PROTEIN mRNA EXPRESSION IN
BOVINE GRANULOSA AND THECA CELLS:
QUANTIFICATION BY REAL-
TIMERT-PCR
By
JUSTIN L. VOGE
Bachelor of Science
University of Wisconsin-River Falls
River Falls, Wisconsin
2000
Submitted to the Faculty of the
Graduate College of the
Oklahoma State University
In partial fulfillment of
the requirements for
the Degree of
MASTER OF SCIENCE
December, 2002
HORMONAL CONTROL OF INSULIN-LIKE GROWTH
FACTOR BINDING-PROTEIN mRNA EXPRESSION IN
BOVI;NE GRANULOSA AND THECA CELLS:
QUANTIFICATION BY REAL-
TIMERT-PCR
Thesis Approved:
ti ~ .
.r '
,4~~!'~tI , U .-twa
----D-ea-n eGradu~te dollg
r' . I r I
IllY
,. .
" I \ r .
11
, .
ACKNOWLEDGEMENTS
( .
I would like to start by thanking the members ofmy committee. First and
foremost Dr. Spicer, thank you for affording me the opportUl)ity to continue to my
education and enlightening me to the world of research. You have continually challenged
me not only to be diligent in learning but to think, I cannot give enouglYtlmnks for all the
insight and knowledge you have given pver the past collple ofyears.
Thank you also to Dr. Rodney Geisert and Dr. Jerry Malayer for serving on my
committee. Dr. Geisert I greatly appreciated your enthusiastic insight into the world of
teaching. Also thank you to Dr. Malayer for the generous use ofyour lab so I c.ould
conduct my project.
My time in Stillwater would not have been as enjoyable without the friendship of
many graduate students. Clay Lents, LeAnn Floyd, Morgan Ashworth, Jason Ross,
Frankie White, Robert Peterson and Jason Schnieder, thank you. I would especially like
to thank my officemate LeAnn Floyd~ thank you for your friendship, without your expert
matchmaking skills I would have never met Julie. Clay Lents, thank you for all your help
during my time here, I greatly appreciate it. I would also like to thank. Dave Goad,
without your help with my project I might still be trying to get things to work. I would
also like to thank Dustin Allen for his technical assistance with the ultrasound study and
Paula Cinnamon for her expert secretarial assistance.
111
I would also like to thank. my family and especially my parents, Rick and Jane
Voge. You have constantly supported me and told me I can go as far as I want. Thank
you for listening to me when I am frustrated, praising me when I do well and still
reminding me at times I can do better. I love you and thank you.
Last but definitely not least, I would like to dedicate this thesis to my wife, Julie.
Julie, I can never tell you how much your love and never-ending support means to me.
You are the best thing that has ever happened to me and I love you more than any words
will ever describe.
IV
c TABLE OF CONTENTS
Chapter Page
I. INTRODUCTION , ..
II. REVIEW OF LITERA11JRE 3'
Function ofOvarian Insulin-like Growth Factors (lGFs)... 3
Hormonal Control ofInsulin-like Growth Factor Binding Proteins
IGFBP-1............ 5
FSH 6
LH : 7
JGFs ~................................ 7
Insulin.................................... 8
EstradioL............................. . 9
IGFBP-2 " _ 10
FSI-I................................................................ 11
LH '....... 11
IGFs 12
Insulin 13
Estradiol.. 14
IGFBP-3....... 15
FSH 16
LH 17
IGFs 17
Insulin 18
Estradio1. .. .. . . . . ... .. . .. . . . . . . ... . . . .. .. . . . .... .... . . . . . .. . . . . . . .... 19
IGFBP-4 20
FSI-I 21
LH 22
IGFs 23
Insulin 24
Estradiol. . .. .. .. . .. .. .. .. . . . . . . .. . . .. . .. .. . . .. .. .. .. . .. . . . .. 25
IGFBP-5 25
FSH 26
LH 27
IGFs 27
Insulin 29
EstradioL............................................................ 30
v
r=
Chapter Page
IGFBP-6 30
FSH 31
LH 31
IGFs '....... 31
Insulin........................................... 32
EstradioI. ....... .. ...... .. .. ............ .. .. ......... .. . ... .. . .. . .... 32
J I,
Quantitative Reverse Transcription-Polymerase Chain Reaction:
Selection ofan Internal Control. , . . . . . . . . .. . . . . . . . . . 33
Literature Cited : ,.. 35
III. HORMONAL CONTROL OF INSULIN-L~ GROWfH <; )
BINDING PROTEIN mRNA EXPRESSION IN BOVINE
GRANULOSA AND THECA CELLS: QUANTIFICATION BY
REAL-TIME RT-PCR
Abstract..................... 50
Introduction ,. 51
Materials and Methods. 53
Results............ 61
Discussion. . .. . . .. . .. . .. . . . . . .. . . . . . . . . .. .. . .. . .. .. . .. . . . . . .. . . . .. . . 65
Literature Cited........................................ 94
TV. SUMMARY AND CONCLUSIONS "...... 101
VI
pc
Table
LIST OF TABLES
Pag
1. Primer (Forward and Reverse) and probe sequences for real-time RT-PCR
amplification ofbovine IOFBP-2, -3 and -4........................... . .. 90
2. Quantitative PCR analysis ofIGFBP-2, -3, and -4 mRNA expression
levels for ExperiJnents 1 and 2....................................... 91
3. Quantitative PCR analysis ofIGFBP-2, -3 and -4 mRNA expression
levels for Experiments 4 and 6 ..... :............ ... . . . . . . .. ..... . . . . . . . . . . . . .. .. .. .. 92
4. Quantitative peR analysis ofIGFBP-2, -3 and -4 mRNA expression
levels for Experiments 3, 5, and 7..................... 93
Vl1
-Figure
LIST OF FIGURES
Page
1. Results ofa test for parallelism between I8S rRNA (+) and
IGFBP-2 (C, Panel A), IGFBP-3 (0, Panel B) and IGFBP-4 (0, Panel C) 75
2. Illustration ofamplification plots for IGFBP-2, -3 and -4 mRNA
and I8S rRNA from cuhured bovine ovarian cells using fluorescent real-
time quantitative RT-PCR 77
3. Effects ofFSH, LH and estradiol on IGFBP-2 (A), IGFBP-3 (B)
and IGFBP-4 (C) mRNA levels (fold gene expression) in small-follicle
(1-5 nun) granulosa cells.................................................... 79
4. Effects ofinsulin, FSH, LH and estradiol on IGFBP-2 (A), IGFBP-3
(B) and IGFBP-4 (C) rnRNA levels (fold gene expression) in small-follicle
(1-5 mm) granulosa cells........................................................... ..... 81
5. Effects ofIGF-l and IGF-2 on IGFBP-2 (A), IGFBP-3 (B) and
IGFBP-4 (C) mRNA levels (fold gene expression) in small-follicle (1-5 mm)
granulosa cells....................................................................... ..... 82
6. Effects of insulin, FSH, LH and estradiol on IGFBP-2 (A), IGFBP-3
(B) and IGFBP-4 (C) mRNA levels (fold gene expression) in large-follicle
(> 7.9 mm) granulosa cells '" 84
7. Effects ofIGF-I, IGF-2, FSH and leptin on IGFBP-2 (A), IGFBP-3
(B) and IGFBP-4 (C) rnRNA levels (fold gene expression) in large-follicle
(> 7.9 rom) granulosa cells 86
8. Effects of insulin, estradiol, and LH on IGFBP-2 (A), IGFBP-3 (B)
and IGFBP-4 (C) mRNA levels (fold gene expression) in theca cells collected
from large follilcles (> 7.9 mm)................................................... ..... 88
9. Effects ofIGF-l and IGF-2 on IGFBP-2 (A), IGFBP-3 (B) and
IGFBP-4 (C) rnRNA levels (fold gene expression) in theca cells collected from
large follicles (> 7.9 mm) 89
10. Schematic model ofevents controlling IGFBP system within the dominant
bovine ovarian follicle............ 104
Vll1
-11 m
2
tolh
CHAPTER I
INTRODUCTION
A loss of reproductive efficiency in animal agricultural systems can result in a
substantial decrease in profitability. For example, in dairy cattle the estimated cost for
each day open after approximately 100 d in milk is $4 per day (Stevenson, 2000).
Therefore, with an average calving interval of 14.5 months, 100 aJlowed days open and a
285 d gestation period, the average dairy cow in the United States is open for SO more
days than optimal costing about $200. Milk cow numbers in the United States as of July,
2002 were estimated at 9.15 million (NASS, 2002), therefore losses associated with
decreased reproductive efficiency are approximately $2 billion per year in the dairy
industry. This loss to Oklahoma dairy farmers is estimated to be about $18 million.
A normal 21-day estrous cycle in cattle is associated with a network of key
hormonal events, of which an increase in knowledge of how these hormones interact
could lead to the development of techniques that would increase reproductive efficiency.
Among these hormones are insulin-like growth factor-l (IGF-l) and IGF-2, which
stimulate mitogenesis and steroidogenesis of ovarian cells (Spicer and Echternkamp,
1995). Bound to IGFs are the high-affinity carrier proteins, insulin-like growth factor
binding proteins (IGFBPs). which modulate the amount ofbioavailable IGFs to the cell.
In cattle, levels of IGF-1 remain relatively constant during follicular growth, while
IGFBPs vary with low levels in dominant follicles and high levels in large subordinate
follicles (Stewart et aI., 1996).
1
2Little information is available at present as to how specific hormones associated
with the estrous cycle and ovarian follicular function regulate the mRNA expression
levels of IGFBPs in cattle. Therefore, the objective of this study was to determine the
hormonal regulation of IGFBP mRNA levels in cultured bbvine granulosa and theca cells
using fluorescent real-time quantitative RT-PCR, with specific focus on the effects of
estradiol, insulin, luteinizing hormone (LH), follicle stimulating hormone (FSH) and
IGFs. 1
"
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1 1 I C:l;lAPTER II I
REVIEW OF LITERA1URE 'f I nl
FUNCTION OF OVARIAN INSULIN-LIKE GROWTH FACTORS (IGFS)
The ovarian IGF system consists ofIGF-l and IGF-2 IGF receptors as welt as six
IOF binding proteins (lGFBP-l thru -6). IGF-l and IGF-2 are related structurally and
functionally to insulin and were first purified and sequenced in 1978 (Rinderkneckt and
Humbel, 1978a; 1978b). IGF-l and IGF-2 are single-ohain polypeptides, which are
highly conserved in regards to their amino acid sequences across specie.s and are
produced locally in many tissues, thus allowing for autocrine and paracrine influences
(Spicer and Echternkamp, 1995). The actions of IGFs are modulated via high affinity
type I and II IOF receptors, part of the tyrosine kinase receptor family, of which IOF -1,
IGF-2 and insulin can all bind to each receptor with varying degrees of affinity (for rev.
see Jones and Clemmons, 1995; Spicer and Echternkamp, 1995).
Within in the ovary, IGF-l and IGF-2 serve as paracrine, autocrine and endocrine
regulators of ovarian function. For example, IOF-l is a potent stimulator of mitog n sis
in ovine (Monniaux and Pisselet, 1992), bovine (Spicer et aI., 1993; Spicer et al., 2002)
and porcine (May et aI., 1988) granulosa cell cultures. Similarly, IGF-1 acts
synergistically with FSH to increase estradiol output via an increase in aromatase activity
in many species (Spi.cer and Echtemkamp, 1995; Silva and Price, 2002; Spicer et aI.,
2002). Furthermore, IGF-l also increases bovine thecal cell proliferation and androgen
production in vitro (Stewart et aI., 1995). However, in cattle levels ofIGF-l in follicular
3
4fluid r1emain relatively constant during the estrous cycle(Echternkamp e a1. 1994' de la
Sota et aI., 1996; Funston et ai., 1996; Stewart et aI., 1996).
lGFBP are a family of six IGF specific carrier proteins, which bind IGFs with a
higher affmity than their receptors and increase the half-life oflGFs (lones and
Clemmons, 1995; Spicer and Echtemkamp et a1., 1995, Rajaram et al. 1997). In the
bovine ovary, IGF-I and IGFBP-3 levels remain relatively cbnstant during follicular
growth while levels ofIGFBP-2, -4 and -5 in follicular fluid fluctuate dramatically uch
that IGFBP-2, -4 and -5 are nearly absent in bovine dominant ovulatory (Funston et aI.,
1996; Spicer et ai., 2001) and nonovulatory (de la Sota et aI., 1996; Stewart et aI., 1996;
Nicholas et at, 2002) follicles, with higher levels found in large subordinate and small
follicles. Moreover, concentrations of estradiol in follicular fluid of cattle are negatively
correlated with f.ollicular content of IGFBP-2, -4 and -S (Stewart et al., 1996; Spicer et
aI., 2001; Rhodes et a1. 2001). Furthermore, IOFBP-2, -3, -4, and -5 inhibit IOF-I-
stimulated ovarian function by sequestering IGF-I (Spicer and Echternkamp, 1995;
Spicer et aI., 1997; Spicer and Chamberlain, 1999; Brown and Braden, 2001). Thus
changes in IGFBP levels due to fluctuating hormonal profiles associated with the estrous
cycle may be modifying the amount ofbioavialable IOF to bind to its receptor and have
an affect on ovarian function. Therefore the aim of this review of the literature was to
determine were IGFBP mRNA are localized within in the ovary as well as to how FSH,
LH, IGFs, insulin and estradiol effect IOFBP production.
HORMONAL CONTROL OF INSULIN-LJKE GI OWTlI ACTOR
BINDING PROTEINS
5
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IGFBP-l
IGFBP-l is a 25-34 kDa protein, which has an equal affinity for both IGF-l and
IGF-2 (Spicer and Echternkamp, 1995' Fowler et aI., 2000). In the rat (Nakatani tal.,
1991) and porcine (Zhou et al., 1996) ovary, localization of IGFBP-l mRNA expression
has not been detected in any tissue as assessed by in situ hybridization. In the human
ovary, IGFBP-l mRNA expression was detectable by in situ hybridization only in
granulosa cells of dominant follicles (EI-Roeiy et aI., 1994). This seems to be a pattern
of expression that is associated with preovulatory follicles that are undergoing the
luteinization process, as IGFBP-l mRNA expression was undetectable by either Northern
blot analysis or RT-PCR in any compartment of the human ovary before the LH surge
(Voutilainen et aI., 1996). More recently, immunocytochemical staining studies revealed
that IGFBP-I was found only in human granulosa cells that were luteinized and co-
staining for hCG (Gersak et aI., 1999). IGFBP-l mRNA expression in the bovine ovary,
in contrast to the human, seems to be an event associated with luteolysis, as an increase in
IGFBP-l expression was seen within 24 to 48 h following prostaglandin-induced luteal
regression when compared to controls as detected by differential display RT-PCR (Sayre
et aI., 2000). However, others have detected a weak signal for IGFBP-l mRNA in the
theca intema of bovine ovaries through RT-PCR (Schams et aI., 1999; Schams et aI.,
2002). Taken together, the ovarian localization and expression of IGFBP-l mRNA is
highly species dependent. Furthermore, an endocrine function of IGFBP-l has been
6postulated in the mouse, as mice overexpressing IOFBP-l mRNA in the liver ha e fI wer
gonadotropin responsive follicles within their ovaries (Froment et al., 2002).
FSH. Emergence of an ovarian fol ioular cohort, consequent growth fol·lowed by
selection and attainment of dominance by one folliole in that ·cohort is associated with a
systemic rise and subsequent decline of follicle-stimulating hormone (FSH) in cattl
(Ginther et al., 1996; Ginther, 2000). Thus FSH plays an important regulatory role in
ovarian follicular growth. This role may in part be through the down-regulation of
IGFBPs, allowing for more bioavailable IGF-l to synergize with FSH to promote
positive ovarian function and development. The effects ofFSH on ovarian IGFBP-l
synthesis seem to vary depending on the experimental situation. For instance, Mason et
a1. (1993) found that FSH in low doses (0.1-10 ng/mt) 'increased IGFBP-1 production in
granulosa cells cultured for 48 h from normal and polycystic human ovaries. In rat
granulosa cells, low doses « 10 ng/ml) of FSH increased IGFBP-1 detected in culture
medium, while increasing doses up to 100 ng/ml caused a decrease in IOFBP-I
production (Adashi et a1., 1990; Adashi et aI., 1991). Consistent with this, Dor et a1.
(1992) found that luteinizing human granulosa cells obtained after in vivo exposure to
FSH/hCG had 52% decreased levels of JGFBP-l compared to controls when cultured for
48 h. However, other studies (Jalkanen et aI., 1989; Ovesen et aI., 1994) have refuted
these results showing no effect ofFSH at doses of 10 to 1000 ng/ml for 48 h on human
granulosa cell IGFBP-1 production in culture when compared to untreated controls.
These differences in part may be explained by differences in culture conditions (i.e.,
duration of exposure to and dose of FSH) as well as cell types (luteinized er u non-
luteinized granulosa cells). t t
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LB. The pulsatile secretion of luteinizing honnone (LH) plays a key role in
maintenanoe of the dominant follicle during follicular growth, and secreted in a surge
stimulates the ovulatory process (Spicer and Echternkamp, 1986; Ginther et aL, 1996).
The role that LH plays in regulating ovarian IGFBP production is still not completely
known. In cultured human granulosa luteal cells, 100 ng/ml of hOG had no effect on
IGFBP-I production (Jalkanen et aL, 1989). Similarly, Voutilainen et a1. (1996) reported
that 10 ng/ml of LH had no effect on IGFBP-l gene expression levels in cultured human
thecal cells. However, other studies have shown that human luteinized granulosa cells
exposed to 10 ng/rol ofhCG for 72 h increased IGFBP-I levels six- to eight-fold over
controls with higher doses (100 and 1000 ng/ml) having no effect (Giudice et aI., 1991 ).
Recently, Greisen et a1. (2002) demonstrated that doses of I and 10 ng/ml ofLH
significantly inhibited IGFBP-l production by human granulosa luteal cells aft r 48 h in
culture. Therefore these studies would suggest that the effects of LH on IGFBp·J are
associated with dose and/or duration of treatment in vitro.
IGFs. IGFs are potent stimulators of ovarian function, however their role in the
regulation ofIGFBPs is still not'completely known. In human granulosa-luteal ceUs,
IGF-1 and IGF-2 decreased the amounts ofIGFBP-l at doses as low as 0.50 and 1.0
ng/ml, respectively (Dor et aI., 1992; Mason et aL, 1993; Poretsky et aI., 1996).
Similarly, IGF-l as weB as IGF-2 significantly decreased both IGFBP-I protein and
8mRNA. levels in human end@1etrial ,cells (Thrailk-ill et a1. 1990'lrwin e a1. 2001).
Likewise, IGF-I Jowered IGFBP-l protein levels in cultured ratchepatocytes ( chaff e,
aI., 1996). In contrast, IGF:.1 and IGF-2 increased IGFBP-llevels in human fetal
fibroblasts (Hill et a1., 1989). Constant infusion ofIGF-l (4 Ilg/gBW/d) to immatur rats
also increased plasma IGFBP-l levels (Oruaz et a1." ]997). The results of these tudies
suggest that the effects of IGFs on IGFBP-l production may be dependent on cell typ ,
Because of the possible endocrine effect ofIGF-l on systemic IGfBP-I, the impact on
follicular ·function may depend on the prevalence of the paracrine versus endocrine
source of IGFBP-l.
Insulin. Insulin is a potent stimulator of both ovarian mitogenesis and
steroidogenesis in several species (see review, Spicer and Echternkamp, 1995). For
example, exogenous administration of insulin to cattle increased follicular fluid
concentrations of estradiol (Simpson et aI., 1994). Insulin appears to Ii> the main
modulator of IGFBP-l gene expression due to the presence of an insulin response
element in the promoter region for IGFBP-I (see review, Fowler et aI., 2000).
Specifically, insulin decreases both IGFBP-I mRNA expression levels and gene
transcription rates in human and rat hepatoma cells (Powell et aI., 1991; Orlowski et a1..
1991) by inhibiting IGFBP-l promoter acitivity (Durham et aI., 1999; Tomizawa et a1.,
2000). In streptozoicin-induced diabetic gilts, levels of IGFBP-l in serum were increased
and conversely IGF-l concentrations in follicular fluid were decreased (Edwards et al.,
1996). In vitro 48 h treatment of human granulosa-luteal cells with 5, 25 or 250 ng/ml
(Holst et aI., 1997) and 100 ng/ml (Poretsky et aI., 1996) of insulin all resulted in a
-9'
decline of IGFBP-l protein accumulation. Greisen et a1. (2002) demonstrat d that
insulin s effect on human granulosa cells was also a dose dependent phenom non with
insulin at concentrations of 100, 400 and 800 J.lU/ml significantly reducing IGFBP-1
protein levels to 37,28 and 24% respectively of controls. Insulin s action in granulo a
cells is not through the classic glucose phosphatidyl-inosital-3 kina e (IP-3) signaling
pathway for insulin, as preincubation with wortmannin (a specific inhibitor ofIP-3) did
not inhibit insulin's negative effect on IGFBP-l production in human granulosa-luteal
cells (Poretsky et aI., 2001). Overall, insulin may enhance IGF action via its inhibition of
both IGFBP-1 protein and mRNA production.
Estradiol. Concentrations of estradiol found in circulation increase in a parallel
fashion with the growth of the dominant follicle as steriodogenic capacity of the
granulosa and theca cells increase. IOF-1 is a potent stimulator of both thecal androgen
and granulosa cell estradiol production in cattle (Spicer and Echternkamp, 1995; St wart
et aI., 1995; Spicer et al., 2002). Similarly, in vivo the loss of estrogenic capability of the
dominant non-ovulatory follicle is associated with an increase in IGFBP-2, -4 and -5
levels in follicular fluid of cattle (Funston et aI., 1996; Stewart et aI., 1996). In vivo
administration of estrogen stimulates IGFBP-1 in human serum (Martikainen et aI., 1992)
and baboon endometrium (Fazleabas et aI., 1989). Ovariectomized rats administered
estradiol had decreased IGFBP-l mRNA and protein levels (Molnar and Murphy, 1994).
However, estradiol had no effect on IOFBP-l protein levels in MCF-7 breast cancer cells
(Kim et aI., 1991). This would suggest that the effect of estradiol on IGFBP·1 is species
and cell type specific.
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IGFBP-2
IGFBP-2 is a 29-40 kDa binding protein which has a greater affinity for IGF-2
than IGF-l (Spicer and Echternkamp, 1995). IGFBP-2 mRNA expression using in situ
hybridization has been shown in both the theca and granulosa cell layers of bovine
ovarian follicles (Armstrong et al., 1998; Yuan et aI., 1998). However, expression
intensity is less in granulosa cells of large healthy follides and increases in granulo a and
theca cells of atretic and subordinate follicles (Armstrong et 811., 1998~ Yuan et al., 1998~.
This is further substantiated in cattle by RT-peR, as estrogen-active follicles had no
detectable IGFBP-2 mRNA in granulosa cells, with increased amounts in theca cells of
follicles with decreased estrogen levels (Schams et aI., 1999; Schams et aI., 2002).
IGFBP-2 mRNA expression evaluated with in situ hybridization was most abundant in
the granulosa cell layer of porcine small and medium follicles, with decreased amounts
present in granulosa cells of preovulatory follicles (Zhou et aI., 1996; Liu et 811.,2000). In
another study, Northern blot analysis indicated that as the follicle progressed in its growth
through the estrous cycle IGFBP-2 mRNA expression decreased in granulosa cells of
gilts (Samaras et 811., 1993). In the human ovary, IOFBP-2 mRNA expression is most
prevalent in theca and granulosa cells of small follicles and theca of dominant follicles in
studies using both Northern blot (Voutilainen et aI., 1996) and in situ hybridization (EI-
Roeiy et aI., 1994). Granulosa cells, but not theca cells of the rat ovary express mRNA
for IGFBP-2 (Nakatani et aI., 1991). IGFBP-2 mRNA expression is highest in granulosa
and theca cells of atretic follicles in the ovine ovary (Besnard et aI., 1996). Taken
together these studies suggest that localization of IGFBP-2 mRNA is decreased in
healthy, growing foUiclesand increases during the process ofatresia. Furthetmore
which cell layer of the follicle expresses IGFBP-2 mRNA may be species d pendent.
p. .) I
FSH. FSH (200 ng/ml) inhibited production of IGFBP-2 in porcine granu 0 a
cells from medium-follicles (4-6 mm) (Mondschein et aI., 1990). Armstrong et a1. (1998)
also demonstrated a decrease in IGFBP-2 mRNA, as detected b¥ RT-POR, in bovine
granulosa cells exposed to 50 ng/ml FSH for 4 days. However, other studies have shown
that FSH increased IGFBP-2 production by equine granulosa cells (Davidson et at., 2002)
and induces its mRNA expression in the ovarian interstitium ofmice (Wandji et aI.,
1998). Recently, Chamberlain and Spicer (2001) reported no effect ofFSH (50 ng/ml) on
IGFBP-2/-5 production by bovine granulosa cells from small~follicles (1-5 rom). Also
treatment with 100 ng/ml of FSH had no significant effect on IGFBP-2 production by
human granulosa-luteal cells (Cataldo et aI., 1993). These differences in the effects of
FSH on IGFBP-2 mRNA expression and protein production may be attributed to different
doses of FSH, length of exposure to treatment as well as species.
LB. In cultured rat thecal cells, LH had no effect on neither IGFBP-2 mRNA
levels (Voutilainen et aI., 1996) nor IGFBP-2 production (Erickson et aI., 1995) when
exposed for 48 h to doses of 10 ng/ml and 20 uU/ml, respectively. Similarly, LH had no
effect in human granulosa-luteal cells (Griesen et aI., 2002) or bovine thecal cells (Spicer
and Chamberlain, 2002) on IGFBP-2 production in vitro. However, when luteinizing
human granulosa cells were exposed to 10 ng/ml of hCG for 72 h in culture a 31 kDa
band corresponding to IGFBP-2 increased when compared to untreated controls (Giudice
12
et aI., 1991). In contrast to this granulosa cells collected from larg mor differentiated
bovine follicles exposed to 100 ng/ml of LH for 24 h decreased lev I f a band that
comigrated with IGFBP-2/-5 (Spicer and Ch~berlain 2002). In agreem nt IGFBP-2
production was inhibited in both human granulosa cells (Cataldo et aI. 1993) and ovine
thecal cells by beG (100 nglml) and LH (lO ng/ml), respectively. In vivo, heG treatment
of weaned sows caused a decrease in IGFBP-2 levels in follicular fluid 0-18 h post-
administration (Howard and Ford, 1992). Tbese levels remained low for 18-24 h and
increased 30-36 h post hCG treatment nearing the, time of ovulatjon (Boward and 'Ford,
1992). Collectively, these results would suggest that the effects of LH on IGRBP-2 may
depend on cell type, length of LH exposure and dose ofLH in vitro. Whether increased
levels of IGFBP-2 could be used as a marker of luteinization in ovulatory follicles will
require further study. r t·' \ " . 1 \. I
, ,
IGFs. In cultured human granulosa cells, treatment with 30 n ImlofIGF-2
decreased IGFBP-21evels by 49% when compared to controls (Cataldo et aI., 1993).
Treatment with [Leu27]IGF-2, an IGF-2 analog which binds only to the type II IGF
receptor (Beukers et a1., 1991), caused the same result as seen with treatment with IGF-2
(Cataldo et al., 1993). Furthermore, IGF-l was without effect, leading to the conclusion
that the decrease in IGFBP-2 was mediated via the type II IGF receptor in human
granulosa cells (Cataldo et a1., 1993). However, in cultured rat theca (Erickson et a1.,
1995), ovine granulosa (Armstrong et a1., 1996), and porcine granulosa (Grimes and
Hammond, 1992) cells, IGFBP-2 protein levels were increased by treatment with IOF-1.
Outside the ovary, treatment with 100 nglml of either IGF-l or IGF-2 for 48 h increased
IGFBP-2 levels in human kidney cells (Boisclair et aI., 1 94) whiL SO nglml had no
effe·ct in vascular smooth muscle cells (Cohick et a1. J993). In contrast, IGF-I inhibi1 d
IGFBP-2 protein production in rat hepatocytes (Scharf et aL 1996). Therefore, the
effects of IGFs on IGFBP-2 may depend on species, cell type as well as the type of IGF
receptor present in that cell type.
I'
Insulin. In cultured porcine (Grimes and Hammond. 1992) and human (Greisen
et aI., 2002) granulosa cells, insulin stimulated production ofIGFBP-2 after 48 h of
treatment. Boisclair et al. (1994) demonstrated that 48 h exposure to 100 ng/rol of insulin
increases IGFBP-2 production in human kidney cells. Furthermore, bovine theca cells
cultured for 24 h in serum free medium containing 100 ng/ml of insulin had inoreased
production ofIGFBP-2 (Spicer and Chamberlain, 2002). A study with rat intestinal cells
revealed that insulin at high (1.0 and 5.0 Jlg/ml) doses increased and at very high (l0.0
Jlg/ml) doses decreased IGFBP-2 protein levels (Guo et aI., 1995). Although IGFBP-2
mRNA levels in the same study were decreased by 5.0 Jlg/ml of insulin, implying th t
low doses may promote secretion of stored IGFBP-2 and high doses are inhibiting
IGFBP-2 at the genomic level (Guo et aI., 1995). Alternatively, the very high doses of
insulin may have cross-reacted with IGF-1 receptors exhibiting an IGF-l effect
previously reported for this cell type, as 20 ng/ml ofIGF-1 decreased IGFBP-2 mRNA
levels compared to untreated controls (Simmons et aI., 1995). Similarly, insulin (10.7 M)
inhibited IGFBP-2 mRNA (Schmid et aI., 1992) and protein levels (Schmid et al., 1992;
Scharf et a1., 1996) in rat hepatocytes. Bovine granulosa cells collected from both small
and large follicles had decreased intensity of a large band that comigrated with IGFBP-
14
2/-5 on a ligand blot after treatment with 100 ng/rol insulin Chamberlain and piC r r
2001; Spicer and Chamberlain, 2002} but whether this band was IGFBP-2, IGFBP-S or
both was not detennined. Contrary to these results, equine granulosa cells exposed to
100 ng/ml of insulin for 48 h had no detectable differences in IGFBP-2 production when
compared to controls (Davidson et a1., 2002). Therefore it seems that regulation of
IGFBP-2 by insulin may depend on species, cell type examined as well as length of
exposure and dose in vitro.
Estradiol. Estradiol increased the relative abundance abundance of IGFBP-2
mRNA transcripts in the theca-interstitial layer ofhypophsectomized rats after 5 days in
vivo (Ricciarelli et aI., 1991) and in human endometrial cells after 14 days in vitro (Liu et
aI., 1997). Similarly, equine granulosa cells treated with 500 ng/ml of estradiol for 24 h
had increased IGFBP-2 protein levels in culture media (Davidson et a1., 2002). However,
in equine (Bridges et aI., 2002), normal healthy woman (San Roman and Magoffin,
1993), porcine (Howard and Ford, ]992) and bovine (Echternkamp et aI., 1994; Funston
et aI., 1996; Stewart et aI., 1996; Austin et aI., 2001) follicles, levels ofIGFBP-2 in
follicular fluid decrease as estradiol levels increase. In cattle these changes in IGFBP-2
in follicular fluid could not be contributed to proteolysis, as little to no cleavage of
IGFBP-2 was demonstrated by follicular fluid of dominant follicles (Spicer et aL, 200 I).
Schams et a1. (1999 and 2002) demonstrated that levels of IGFBP-2 mRNA expression
levels as detected by RT-PCR in thecal cell layer of cattle decreased as estradiol levels
increased. In vitro, estradiol had no effect on IGFBP-2 protein in bovine granulosa cells
(Spicer and Chamberlain, 2002). These studies taken together suggest that estradiol's
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effect on IGFBP-2 may be species a well. a cell specific. Furthermor estradiol is m r
than ,likely changing levels ofIGFBP-2 through control of its mRNA.
IGFBP-3
IGFBP-3, which binds both IOF-I and -2 with equal affinity, is a 150 kDa protein
that is visualized as a doublet between 40 and 44 kDa on a western ligand blot (Spicer
and Echternkamp, 1995). Whether or not IGFBP-3 mRNA expression is localized to a
particular ovarian compartment appears to vary between species and technique used. For
example, in the bovine ovary in situ hybridization could only detect IGFBP-3 mRNA
expression in the granulosa cell layer in 2 of28 follicles studied (Yuan et a1., 1998).
Similarly, another study using in situ hybridization detected IGFBP-3 mRNA in the
oocyte of preantral follicles and theca extema, but not granulosa cells of cattle
(Armstrong et aI., 2002). However, using RT-PCR IOFBP-3 mRNA expression was
detectable in all follicle classes in both granulosa and theca cells of cattle (Schams et a1.,
1999; Voge et aI., 2001; Schams et a1., 2002). In agreement with the latter observations,
IGFBP-3 mRNA expression in porcine granulosa cells was constant in all follicles and in
theca cells of healthy follicles (Wandji et aI., 2000). The acid labile subunit, which forms
a ternary complex with IGF-1 and IGFBP-3, was found in preantral and small antral
follicle granulosa cells (Wandji et aI., 2001). In contrast, others have not detected
IGFBP-3 mRNA expression in porcine granulosa cells using in situ hybridization (Zhou
et aI., 1996) or Northern blot analysis (Samaras et a1., 1992). However, the latter study
did detect IGFBP-3 mRNA expression in the corpus luteum (eL) and theca cells of the
porcine ovary (Samaras et aI., 1992). IGFBP-3 mRNA expression was not detectable by
Northern blot (Voutilainen et aI., 1996), but was detectable by in situ hybridization (El-
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Roeiy et ai., 1994) in theca cells of small follicle and th ca and granulosa c 11 of large
dominant follicles in the human ovary. To date IGFBP-3 mRNA expression has b n .
limited to the CL oftherat ovary (Nakatani et aI., 1991). Collectively IGFBP- mRNA
is detectable in both theca and granulosa ceU compartments ofco , pig and human
follicles but sensitive techniques (e.g. RT-PCR) are necessary to detect the low levels of
expression.
FSH. Exogenous FSH administered to cattle had no effect on the amount of
IGFBP-3 found in follicular fluid of large follicles (Echternkamp et at, 1994). Similarly~
no change was seen in follicular IGFBP-3 levels during endogenQus changes in serum
FSH of cattle (Austin et ai., 2001) and FSH had no influence on IGFBP-3 production in
small-follicle granulosa cells after 24 h of treatment (Chamberlain and Spicer, 2002). In
contrast, Ingman et al. (2'000) reported that bovine granulosa cells associated with the
oocyte-cumulus complex in small follicles showed an increase in IGfBP-3 production in
vitro after 24 h exposure to FSH (10 ng/ml) .. IGFBP-3 production by granulosa cell
cultured from small (1-5 mm) porcine follicles (Mondschein et al., 1990) and human
polycystic (San Roman and Magoffin, 1992) ovaries was attenuated by exposure to FSH.
These data taken together would suggest that the granulosa cell response to FSH on
IGFBP-3 production may be species dependent but also may be influenced by culture
conditions.
LB. In vivo levels of I-GFBP-3 remained constant among follicles both befor
and after the ovulatory surgeof LH in cattle (Funston et a1. 1996). Similarly, treatment
with LH had no effect 00 IGFBP-3 protein levels in human Giudic et a1., 1991' Or i n
et aI., 2002) or bovine granulosa cells (Spicer and Chamberlain 2002) a well as having
no etTect on human thecal cellIGFBP-3 mRNA levels (Vootilainen et aI., 1996). Ie
However, in vivo administration of 500 IU ofhCG to sows resulted in a decrease in
follicular fluid IGFBP-3 from 0 to 36 h but decreases in plasma IGFBP-3 likely
accounted for the intrafollicular changes (Howard and Ford, 1992). Treatment ofhuman
thecal cells with 100 ng/ml ofhCG for 48 h blocked production ofIGFBP-3 (San Roman
and Magoffin, 1992). In contrast, LH increases IGFBP-3, mRNA theGal cells from rats
(Erickson et aI., 1995) and increases JGFBP-3 production in theca cells from cattle
(Spicer and Chamberlain, 2002). Thus the role ofLH.in regulating IGFBP-3 may depend
on species as well as cell type examined. Interestingly, Fraser et al. (2000) demonstrated
that administration ofhCG to late-luteal human patients, in order to re cue the CL from
luteolysis, resulted in an increase in IGFBP-3 mRNA levels in endothelial cells ofth CL
similar to early-luteal levels. High IGFBP-3 mRNA expression was identified in
endothelial cells of microvessels of the primate CL (Fraser et al., 1998). Whether
IGFBP-3 production by theca cells is due to possible contaminating endothelial cells
remains to be determined.
IG Fs. In human luteinized granulosa cells treatment with IGF-1 and IGF-2
stimulated IGFBP-3 release by at least 3-fold in a dose-dependent manner (Cataldo et aI.,
1993). Similarly, Grimes and Hammond (1992) demonstrated that IOF-I treatment for
--
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24 h increased IOFBP-,) protein and mRNA Ie els in moderately dif eT ntiat d por ine
granulosa cells. Furthermore treatment with SO nglml of IGF-l for 24 h furtbr
stimulated an FSH-induced increase in IOFBP-3 levels in bovine granulosa cells (Ingman
et a!., 2001). In other cell types, treatment with IGF-I caused an increase in IGFBP-3
protein concentrations in human (Camacho-Hubner et aI., 1992) as well as bovine (Bal
and Conover, 1992) fibroblasts by 2- and 6-fold. respectively. Conover et a1. (1993)
further illustrated that treatment with 10 nM ofIGF-2 for 24 h was also able to stimulate
IGFBP-3 production in human fibroblasts. IOF-I also stimulates IGFBP-3 rnRNA
synthesis in bovine endothelial cells (Eronder et a1.. 1997). In agreement, both IGFBP-3
mRNA and protein levels were increased in a dose- and time-dependent manner, with this
effect first observed at 3 h and plateuing at 24 h of treatment in human osteosarcoma cells
(Rosato et aI., 2001). Overall in most cell typ.es examined, the role ofIOFs is to
stimulate production and release ofIGFBP-3. Since IGFBP-3 increases the half-life of
IGFs, IGF-l-induced increases in local production ofIGFBP-3 could provide a local
"reserve" of IOF-l.
Insulin. Overall the effects of insulin on IOFSP-3 production seem to vary
among both species and cell type. In human granulosa-luteal cells, 2000 ng/ml of insulin
for 3 to 5 d was without effect on IOFBP-3 production (Cataldo et aI., 1993). This was
further confirmed by a lack of effect of 100 nglml of insulin on IGFBP-3 protein levels in
granulosa and thecal cells ,collected from large bovine follicles cultured for 24 h
(Chamberlain and Spicer, 2001; Spicer and Chamberlain. 2002). Similarly.IGFBP-3
mRNA expression was not changed by addition of insulin to medium of cultured human
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retinal pigment epithelial cells (Feldman and Randolph 19 4). In contrast porcirn
granulosa cells obtained from medium (4 to 6 rom) sized follicles had increased IGFBP-3
protein levels after treatment with insulin at concentration of 17 nM or greater for 48 h
(Grimes and Hammond, 1992). In vivo, systemic levels of IGPBP-3 and insulin are
positively correlated in gilts (Edwards et aI., 1996), humans (Ripa et aI., 2002) and cattle
(Cohick et aI., 1992). Thus, intrafollicular changes in IGFBP-3 may reflect changes in
systemic IGFBP-3 under certain situations.
Estradiol. Thecal-interstitial cell mRNA expression for IGFBP-3 was decreased
by exogenous administration of estrogens to hypopysectomized rats (Ricciarelli et aI.,
1992). Spicer and Chamberlain (2002) demonstrated that 500 ng/ml of estradiol had no
effect on bovine thecal (large follicles) or granulosa (small and large follicles) cell
IGFBP-3 production after 24 h exposure in vitro. Likewise, estradiol had no effect on
IGFBP-3 protein levels in porcine granulosa cells (Mondschein et aI., 1990) or in
cultured human fibroblasts (Camacho-Hubner et aI., 1992). Outside the ovary, estradiol
had an inhibitory effect on IGFBP-3 mRNA and protein in cultures of human endometrial
cells (Liu et aI., 1997) as well as decreasing basal levels of IGFBP-3 protein by 25% in
MCF-7 breast cancer cells (Martin et a1., 1995). Estradiol also increased amounts of
IGFBP-3 produced by primary cultures of rat osteoblasts (Schmid et aI., 1989). In
estrogen active follicles of normal women, IGFBP-3 levels decreased as these follicles
grew (San Roman and Magoffin, 1993). In mares, follicular fluid IGFBP-3 levels
increase with follicular development (Bridges et a1., 2002) However, in follicular fluid of
cattle, levels of IGFBP-3 remain constant (de la Sota et aI., 1996; Stewart et aI., 1996).
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Because exogenous estradiol administered to ovariectomized cattle increases serum
IGFBP-3 I.evels, via increased growth hormone levels (Simpson et a1. 1997), systemic
changes in IOFBP-3 may account for intrafbllicu1ar changes in IOFBP-3. The
differences among studies as to the influence of estradiol on IOFBP-3 in vitro production
may be in part attributed to species differences, dose and duration of treatment as well as
cell type.
, .
IGFBP-4
Approximately 24 kDa in size, IGFBP-4 binds both IOF-l and IGF-2 with an
equal affinity (Spicer and Echternkamp, 1995). In the bovine ovary as assessed by in situ
hybridization, IGFBP-4 mRNA expression was found to be localized to theca cells of
heaJthy antral follicles and granulosa cells of atretic follicles (Armstrong et al., 1998).
However, RT-PCR detected IOFBP-4 mRNA expression in granulosa and theca cells
regardless of the follicles estrogenic capacity (Schams et aI., 1999; Schams et aI., 2002).
In the ovine ovary IOFBP-4 mRNA was localized in theca cells of both healthy and
atretic follicles examined by in situ hybridization (Besnard et aI., 1996). Similar to the
bovine, IGFBP-4 mRNA expression in the porcine ovary was found to be greatest in
theca cells of growing follicles and granulosa cells of atretic follicles using in situ
hybridization (Zhou et aI., 1996). Liu et al. (2000) found IGFBP-4 mRNA expression
using in situ hybridization in both granulosa and theca cells, with the greatest abundance
found in theca cells of large porcine follicles. In humans, IOFBP-4 mRNA expression is
located in both granulosa and theca cells using Northern Blot analysis (Vouitalainen et
aI., 1996) and in situ hybridization (EI-Roeiy et aI., 1994) techniques. Rat ovarian
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IGFBP-4 mR A expression appears to be confined to granulosll cells of atretic antral and
preantral follicles (Nakatani et aI., 1991; Erickson et a1., 1992). Whether or not IGFBP-4
mRNA expression in granulosa cells can be used as a marker of follicular health requires
further elucidation of the meohanisms controlling its expression.
r FSH. Grimes et aI. (1994) reported that FSH stimulation of porcine granulosa
cells from follicles 4 to 6 mm in size increased IGFBP-4 levels in a dose-dependent
manner. However, the same study also found no effects ofFSH on IGFBP-4 mRNA
expression in the same cell type (Grimes et aI., 1994). In the rat, IGFBP-4 mRNA has
been shown to be localized to granulosa cells of antral follicles and this signal was absent
during the proestrus (high FSH) period of preovulatory follicles (Erickson etal., 1992).
Another study revealed that low doses (3 ng/ml) of FSH increased while high doses (30
and 100 ng/ml) inhibited IGFBP-4 production by rat granulosa cells (Erickson et aI.,
1994). Similarly, rat granulosa cells had decreased levels ofIOFBP-4 protein and
elimination of detectable IGFBP-4 mRNA after 72 h treatment with FSH (Liu et at,
1993). However, Chambedain and Spicer (2001) found that 24 h exposure to 50 ng/ml of
FSH had no impact on IGFBP-4 production in bovine granulosa cells collected from
small follicles (1 to 5 mm).
In FSH-treated rat granulosa cell cultures, two molecular weight bands (21.5 and
17.5 kDa) were detected with an IGFBP-4 antibody indicating the possibility ofan FSH
induced IGFBP-4 protease (Liu et a\., 1993). Recently, this protease has been identified
as pregnancy associated plasma protein-A (PAPP-A) in both humans (Conover et aI.,
2001) and fann animal species (Mazerbourg et aI., 2001). Taken together these data
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'I LH. Stimulation of both ovine (Armstrong et aI., 1996) and bovine (Armstrong et
al" 1998) thecal cells with LH (10 and 100 ng/ml, respectively) resulted in an increase of
IGFBP-4 protein and mRNA in each respectively. Similarly, human granulosa-luteal
cells exposed to 10 ng/ml of hCG for 72 h had increased lev.els of IGFBP-4 pre ent in
culture medium (Gjudice et aI., 1991). In vivo, PMSG primed rats had a 3.5·fold
increase in IGFBp·4 mRNA -expression level.s by 24 h post administx:ation of 151U of
hCG (Putowski et aI., 1997). However, Liu and Ling (1993) demonstra\ed that LH
blocked the increase oflGFBP-4 production in a dose-dependent manner in rat granulosa
cells. In both small- and large-follicle granulosa (but not theca), cells collected from
cattle, LH was able to decrease IGFBP-4 production after 24 h of treatment (Spicer and
Chamberlain, 2002). In porcine follicles, levels of LH receptor mRNA were iner a ed
whereas IGFBP-4 mRNA levels were decreased in 2 to 6 mm versus 8 rnrn follicles,
suggesting that LH may suppress IGFBP-4 mRNA expression (Liu et ai., 2000). To
further substantiate this, preovulatory follicles in proestrous (after the FSHlLH surge) rats
had no detectable signal for IGFBP-4 mRNA (Erickson et al., 1992). Whether LH, like
FSH, induces an IGFBP-4 protease, remains to be determined but may account for the
differential/opposing effects of LH on levels of IGFBP-4 protein and mRNA previously
reported.
suggest that decreases in iGFBP-4 protein may b due to an increase in prot~e~ct~vity
as well as a decrease in IGFBP-4 mRNA levels.
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IGFs. The role oUGFs in. the regulation oflGR [P-4 seems to vary with c II
type. In moderately differentiated porcine granulosa cells IGF-l had no fIect on I Jl
IGFBP-4 protein or mRNA concentrations in vitro (Grimes et al. 1994). Cultured rat
hepatocytes differed in that 100 nM oflGF-l increa ed IGFBP-4 production when
oompared to controls (Scharf et aI., 1996). However, in mouse granulosa cells 48 h
exposure to IGF-l decreased levels ofIGFBP-4 in culture medium (Adashi et aI., 1997).
Similarly, treatment with both IGF-I and IGF-2 caused a decrease in IGFBP-4 protein in
human endometrium (Irwin et aI., 1995) and human fibroblasts (Conover et a1., 1993).
This decrease was likely mediated through an increase in protease activity as detection of
a 16-kDa band that bound immunoreactive IGFBP-4 increased at the same time (Irwin et
a1., 1995). In rat thecal (Erickson et a1., 1995), porcine vascular smooth muscle (Cohick
et a1., 1993) and rat myometrial cells (Huynh, 2000) cells, treatment with IGF-l increased
IGFBP-4 mRNA expression levels. However, in these same studies, levels ofIGFBP-4
protein were decreased by IGF-1 treatment, further substantiating the role for IGFBP-4
protease activity. The role oflGF-l may be to bind IGFBP-4, thus exposing the cleavage
site oflGFBP-4 to the protease. For example, when IGF-l was added to rat granulosa
cell cultures it activated the proteolysis of radioiabelled IGFBP-4 (Iwashita et aI., 1998).
Furthermore, addition ofLR3-IGF-l, which does not bind IGFBP-4, did not result in
cleavage ofIGFBP-4 further indicating that IGF-l must bind IGFBP-4 to expose its
cleavage site to the protease (Iwashita et aI., 1998). Similarly, Mazerbourg et a1. (2000)
demonstrated that addition of IGFBP-2 and -3 to culture decreased IGFBP-4 proteolysis,
though this was reversed upon addition ofIGF-I and IGF-2. As mentioned earlier, in
humans (Conover et aI., 2001) as well as farm animal species (Mazerbourg et al., 200 1),
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IGFBP-4 cleavage has been attributed to PAPP-A an IG BP-4 pedfic pr tea wh
proteolytic activity depends on IGF-l binding IGFBP-4. Therefore th rol oflGFs in
IGFBP-4 production may be to stabilize the mRNA providing a constant source of
IGFBP-4 protein, with decreasing protein levels. found in media attributed to an increase
in bound IGFs exposing the cleavage site for increased IGFBP-4 protease aotivity
(Huynh, 2000).
. Insulin. Recently, treatment of bovine small-follicle granulosa cells with 100
ng/ml of insulin for 24 h proved inhibitory to IGFBP-4 production (Spicer and
Chamberlain, 2002). However, insulin was without affect on IGFBP-4 production in
theca or granulosa cells of large bovine follicles (Chamberlain and Spicer, 2001; Spicer
and Chamberlain, 2002). In human granulosa cells, insulin inhibited IGFBP-4
accumulation in culture medium (Greisen et aI., 2002). Outside the ovary, Irwin et al.
(1995) demonstrated that insulin had a dose-dependent effect in human endometrial
stromal cells, with doses of less than 10 ng/ml and that of 100 ng/ml bing without ffect
and stimulatory to IGFBP-4 production, respectively. Insulin was also stimulatory to
IOFBP-4 mRNA and protein levels in porcine smooth vascular smooth muscle cells
(Cohick et aI., 1993) as well as IGFBP-4 protein levels in human fibroblasts (Camacho-
Hubner et aI., 1992). In contrast, insulin was without effect when applied to
neuroblastoma (Babajko et aI., )997) or fibroblasts (Conover et aI., 1993). These studies
suggest that insulin's effect on IGFBP-4 may be a'dose as well as species and cell
specific phenomenon.
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Estradiol. Until recently littlehas been known as to the direct effects of estradiol
on IGPBP-4 production in the bovine ovary. Spicer and Chamberlain 2002) ttl.
demonstrated that 500 ng/ml of estradiol for 24 h significantly deer ased bovin mall-
and large-follicle granulosa cell IGFBP-4 production in vitro. Similarly the future q
dominant follicle in the majority of ovarian follicular cohorts of cattle had thehighest
levels-of estradiol and lowest levels ofIGFBP-4, when compared to fufure subordinate
follicles (Mihm et ai., 2000). Some ofthis decrease may in part be due to proteolysis. a
cleavage of IGFBP-4 by follicular fluid of cattle was positively correlated with estradiol
levels in cattle (Spicer et a1., 2001). In other tissues, such as human osteoblasts (Kassem
et aI., 1996) and MCF-7 human breast cancer cells (Qin et aI., 1999) esttadiol treatment
increases IGFBP-4 protein and (or) mRNA levels. Similarly, adminstration of estradiol
to ovariectomized rats increased uterine expression levels ofIGFBP-4 mRNA (Molnar
and Murphy, 1994). However, estradiol was without effect on IGFBP-4 protein in human
fibroblasts (Conover et a1., 1993) or its mRNA in the hypophysectomized rat ovary
(Putowski et aI., 1997). This taken together would suggest that the effects ofestradiol on
IGFBP-4 may depend on cell type and species examined and (or) the production of an
IGFBP-4 protease in that cell type.
IGFBP-S
IGFBP-5 is 29-3] kDa protein, which·binds IGF-2 to a higher degree than IGF-l
(Spicer and Echtemkamp, 1995). To date, few studies have examined the localization of
IGFBP-5 mRNA expression in the ovary. IGFBP-5 mRNA expression was detected with
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RT-PCR in both granulosa and theca ceLIs in the bovine 0 ary with: r~ulo a It t f'
IGFBP-5 mRNA levels decreasing as follicular estradiol Jevels increased (Schams et aI.,
1999; Schams et al. 2002). In situ hybridization revealed IGFBP-5 mRNA expression to
be associated with granulosa cells of atretic follicles and theca c II of healthy follicles in
sheep (Besnard et al., 1996). EI-Roeiy et a1. (1994) demonstrated the localization of
IGFBP-5 mRNA expression in theca, granulosa and stroma of all human ovarian
follicles. However, only theca cells from human ovaries had dete table IGFBP-S mRNA
expression when examined by Northern Blot analysis (Voutilainen et ai., 1996). In the
porcine ovary, IGFBP-5 mRNA was not detected in ovarian follicles, but was in the
capillaries of luteal tissue (Zhou et a1., 1996). In the rat ovary, antral follicles are devoid
ofIGFBP-5 mRNA expression, whil.e atretic preantral follicles are the main source of
IGFBP-5 mRNA expression detected by in situ hybridization (Erickson et aI., 1992;
Putowski et al., 1995,). Whether or not local production of IGFBP-5 is contributing to
follicular fluid levels ofIGFBP-5, and what hormonal mechanisms ar controJling
ovarian IGFBP-5 production needs further study in bovine as well as other species.
FSH. Synthesis ofIGFBP-5 by bovine (Chamberlain and Spicer, 2001; Ingman
et a1.. 2000) and ovine (Armstrong et aI., 1996) granulosa ceLIs was not affected by
treatment with FSH. However, IGF-I-stimulated production ofIGFBP-5 protein and
mRNA in cultured porcine granulosa cells was dramatically reduced by concurrent
treatment with FSH (Grimes et aI., 1994). Similarly, that stimulation of rat granulosa
cells with high doses ofFSH (100 ng/ml) reduces a 28-29 kDa protein corresponding to
IGFBP-5 (Adashi et al., 1993; Fielder et aI., 1993). Liu et a1. (1993) also demonstrated
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that both IGFBP-5 prote.n and mRNA levels, as detected by ligand blo ting and orthern
blot analysis respectively, are reduced in cultured rat granulosa cells after exposure to
FSH conditioned media. Some of this reduction in IGFBP-S may be due to an FSH-
induced protease, as incubation with medium from FSH-treated rat granulosa cells
degraded exogenously added IGPBP~5 (Liu et aI., 1993) and follicular fluid from
dominant follicles of cows (Spicer et aI., 2001) and mares (Bridges et aI., 2002) contain
IGFBP-5 protease activity. This suggests that FSH may regulate granulosa cell IGFBP-5
production through both changes in gene traFlscription and post-transcriptionally by
induction of a protease in ovarian granulosa cells.
.. . ;\
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LH. In vivo, numbers of thecal LHthCG binding sites were negatively correlated
with IGFBP-5 protein concentrations in follicular fluid of cattle (Stewart et al. , 1996). In
vitro, IGFBP-2/-5 production was decreased by 100 ng/ml of LH in bovine granulosa
cells isolated from large-follicles (Spicer and Chamberlain, 2002), whereas bovin th cal
IGFBP-5 production was not affected by LH (Spicer and Chamberlain, 2002). However,
Voutilainen et al. (1996) reported that LH increased IGFBP-5 mRNA levels in cultured
human thecal cells. These results suggest that species and cell type may influence the
effect of LH on IGFBP-5 production within the follicle, and that LH may playa
regulatory role in follicular IGFBP-5 production in cattle and humans.
IGFs. Moderately differentiated porcine granulosa cells treated with IGF-1 for 48
h increased IGFBP-5 protein and mRNA expression in vitro (Grimes et at, 1994).
Likewise, the addition of 100 ng/ro1 of IGF-I to rat granulosa cells for 72 h significantly
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increased IGFBP-5 protein levels (Fielder et al. J993). Fielder etal. (1993) al 0. n
demonstrated that IGF-l was able to block an FSH induced decrease in IGFBP-5.
Furthermore, treatment with IOF-l was found to be both dose- and titTle-dependent in rat
granulosa cells such that stimulation oflGFBP-5 concentrations as' analyzed by western
ligand blotting were fITst detectable at a dose of 1ng/ml, continuing to increase in
intensity up to 100 ng/ml ofiOF-l (Adashi et al., 1994). The time-dependent increa es in
IGFBP-5 induced by IGF-l were first detected at 24 h and continued to increase until
termination of the experiment at 72 h (Adashi et aI., 1994). The effects ifIGF-l are
thought to be mediated via the type I IGF receptor alone, as 10 and I QO ng/rol of des( 1-3)
IGF-l, an IGF-l analog which binds IGFBP with a lower affinity, was a more potent
stimulator ofIGFBP-5 accumulation than IOF-l (Adasbi et al, 1994). To further
substantiate this, insulin was only effective at doses of 10,000 ng/ml, which likely cross-
react with the type I IGF receptor (Adashi et al., 1994). Outside the ovary in cultured
human osteoblasts, addition of 0.5 and 10 nM IGF-l caused a dose depend nt increa e in
IGFBP-5 protein levels by 2.6- and 10-fold, respectively (Conover and Kiefer, 1993).
However, these changes in IGFBP-5 protein levels were not accompanied by similar
changes in mRNA expression (Conover and Kiefer, 1993). Similarly, in human
fibroblasts addition ofIGF-l and IGF-2 caused a 6- to 8-fold increase in lOFBP-5 protein
levels, while increasing IGFBP-5 mRNA levels by only 43% (Camacho-Hubner et ai.,
1992). IGF-l may regulate IGFBP-5 levels posttranscriptionally by protecting it from
IGFBP-5 proteolytic activity, as the proteolytic breakdown of IGFBP-5 decreased upon
the addition oflGF-l to rat granulosa cell culture (Fielder et aI., 1993). This protective
action of IGF-l on IGFBP-5 breakdown was further substantiated in ovine articular
2chondrocytes, as radiolabelled IGFBP-S was not significantly degraded when 100 ng/ml
ofIGF-1 was added to culture (Sunic et a1. 1998). Ho ever treatment with )'00 ng/ml
of Des(1-3)IGF-l and LR3IGF-l which do not bind IGFBPs resulted in a signifioant
reduction in IGFBP-S exposed to chondrocyte conditioned medium (Sunic et aL 1998).
This IGF-l-induced decrease in proteolysis ofIGFBP-5 is the opposite of its effect on
IGFBB-4 proteolysis, as PAPP-A proteolysis ofIGFBP-4 is increased by IOF-I (lwashita
et al., 1998; Mazerbourg et aI., 2000; Mazerbourg et aI., 2001). Furtherrnor~, IOFBP-5
may serve to increase stores of IGFs around the cell surface as it is known to be
associated with the extra cellular matrix in bovine gran.ulosa cells (Ingman et aI., 2000).
I.
Insulin. Until recently little infonnation has been available as how insulin
directly regulates ovarian IGFBP-5 production. In bovine thecal cells treated with 100
ng/ml of insulin for 24 h, IGFBP-5 production was significantly increased (Chamberlain
and Spicer, 2001; Spicer and Chamberlain, 2002). In contrast, the same dose of inulin
attenuated production of a large band that comigrated with IGfBP-2/-5 in granulosa cells
from small and large bovine follicles (Chamberlain and Spicer, 2001; Spicer and
Chamberlain, 2002), but whether this was IGFBP-2, IGFBP-5 or both was not
determined. Furthermore, insulin was without effect on IGFBP-S production in equine
granulosa cells (Davidson et aI., 2002) and bovine aortic endothelial cells (Dahlfors and
Arnqvist, 2000). Thus the role of insulin in regulating IGFBP-5 production may depend
on cell type as well as species. Overall insulin may be having a positive affect on bovine
granulosa cell function by decreasing IGFBP-5 levels allowing for more free IGF-I to be
available to its receptor.
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Estradiol. Levels of a molecular weight band that co-migrated ith IOFBP":2/-5
on a ligand blot decreased in bovine large-follicle granulosa cells after treatment with
estradiol for 24 h (Spicer and Chamberlain, 2002). However, the same study found no
effect on either thecal or small-follicle granulosa cell IGFBP-S production. Consistent
with this, equine granulosa cells exposed to 500 ng/ml of estradiol for 24 h had no effect
on IGFBP-5 production (Davidson et a!., 2002). Similarly, estradiol evoked no change in
IGFBP-5 protein production in osteoblasts (Conover and Kiefer, ]99:3). However, levels
of IGFBP-5 are lower in follicular fluid of dominant versus subordinate follicles in cattle
(Stewart et a1., 1996; Spicer et aI., 2001). As mentioned earlier, some if-these changes
may be attributed to proteolysis, as follicular fluid from large estrogen-active follicles in
horses (Bridges et ai, 2002) and cattle (Spicer et aI., 2001) cleaved fOFBP-5. Therefore,
changes in IGFBP-S in follicular fluid may be in part due to an increase in proteolysis of
IGFBP-5 and a decrease in its granulosa cell production. Recently, Overgaard et a!.
(2001) characterized an IGFBP-5 specific metalloproteinase called PAPP-A2 from
mammalian cells, which cleaved IGFBP-5 but not IGFBP-4, Whether the majority of
IGFBP-S proteolysis is due to the IGFBP-5 specific protease, PAPP-A2 (Overgaard et al,.
2001), or some other IGFBP proteases such as PAPP-A (Laursen et aI., 2001) or
kallikrein K2 (Rehault et aI., 2001) in the ovarian follicle will require further study.
IGFBP-6
IGFBP-6 is a 21-32 kDa protein that was first identified in adult serum and binds
IGF-2 with a greater affinity than IGF-l (Spicer and Echternkamp, 1995). In the bovine
·I
•• •
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ovary IGFBP-6 mRNA expression was detected in both granulosa and theca ceLls using
RT-PCR (Schams et aI., 1999; Schams et aI., 2002). Similarly human ovaries-contained
IGFBP-6 mRNA expression in granulosa and theca cells as detected with RI-PCR
(Voutilainen et aI., 1996) but not with in situ hybridization (EI-Roeiy et aI., 1994), Rat
ovarian IGFBP-6 mRNA expression was detected by ribonuclease protection assay and is
limited to the theca cell layer (Rohan et aI., J993).
FSH. IGFBP-6 transcripts have been found to be expressed in the ovaries of
PMSG-primed rats (Shimaski et aI., 1991). Hypophysectiomized rats have a 2.3-fold
greater whole ovarian IGFBP-6 gene transcpripts,than intact controls (Rohan et ai.,
1993). When exogenous FSH was given back to these animals ~t resulted in a 2.4-fold
decrease in IGFBP-6 compared to non-treated hypophysectomized a,nimals (Rohan et aI.,
1993). However, IGFBP-6 gene expression was limited to the theca cell layer,
suggesting that a granulosa cell intermediate stimulated by FSH was decreasing thecal
IGFBP-6 gene transcription (Rohan et a1., 1993).
LH. Little to no work has been done as to the effects of LH on ovarian IGFBP-6
production. Voutilainen et al. (1996) demonstrated IGFBP-6 mRNA expression in
ovarian tissue using RT-PCR, however this signal was not present in cultured theca cells
treated with LH as detected by Northern Blot analysis.
IGFs. To date, no data are available as to the affect ofIGF-1 or IGF-2 on
IGFBP-6 production in the ovary. However, neither IGF-I nor IGF-2 were able to
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influence IGFBP-6 mRNA expression levels in rat osteoblasts (Gabbitas and Canalis
1997). Furthermore, levels of IGFBP-6 mRNA transcripts were not affected by addition
I
of IGF-l to culture medium of human retinal pigment epithelial cells (Feldman and
Randolph, 1994). However, in neuroblastoma cells treatment with IGF-l induced
IGFBP-6 protein production and detection of its mRNA by RT-PCR (Babajko et aI.,
1997). Taken together these studies suggest the effect ofIGFs on IGFBP-6 mRNA and
protein levels may depend on cell type studied.
Insulin. To date no information is available on insulin regulation ofIGFBP-6 in
any ovarian cell type. In retinal pigment epithelial cells (Feldman and Randolph, 1994)
and neuroblastoma cells (Babajko et aI., 1997), insulin was unable to influence IGFBP-6
protein or mRNA expression levels. Insulin does not seem to be as potent a modulator of
IGFBP-6 production when compared to other IGFBPs.
Estradiol. Limited information is available as to the effects of estradiol on
IGFBP-6. Treatment of hypophysectomized rats with diethylstilbestrol (DES) caused an
approximate 2.5-fold decrease in whole ovarian transcripts of IGFBP-6 (Rohan et aI.,
1993). This was further attenuated by treatment of DES + FSH, suggesting that a
granulosa cell intermediate was causing this decrease (Rohan et aI., 1993). However, in
MCF-7 cells treatment with 10 nM of estrogen increased IGFBP-6 by 1.5- to 2-fold after
96 h versus untreated controls (Martin et aI., 1995).
,,
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QUANTITATIVE REVERSE TRANSCRIPTION-POLYMERASE CHAIN
REACTION: SELECTION OF AN INTERNAL CONTROL
Survival, growth and differentiation of cells is often reflected in different patterns
of gene expression. For this reason, the importance of being able to quantitate mRNA
transcription levels of specific genes has been extremely important in many areas of
research today. Many techniques are used to accomplish this goal and among them are
quantitative real-time RT-PCR, northern blot analysis, RNAse protection assays and in
situ hybridization. However, errors in the quantitation of mRNA transcripts are easily
compounded by any variation in starting material between samples, which can lead to
false differences in quantification of a particular gene. Therefore, a housekeeping or
normalizing gene is needed to correct for loading variation of the target gene of interest.
Housekeeping genes are defined as a cellular RNA that is expressed at constant levels
among different tissues, at all stages of development and should be unaffected by
experimental treatments (Bustin, 2000). Suzuki et a1. (2000) reported that the three most
common genes used for this purpose are glyceraldehyde-3-phosphate dehydrogenase
(GAPDH), ~-actin and 18S rRNA. Many studies have looked if the experimental
paradigm affects expression of these genes. For instance, in serum stimul.ated fibroblasts
serum increased the total amount of mRNA found in these cells while not increasing the
amount of total RNA (Schmittgen and Zakrajsek, 2000). When not normalized for RNA
content serum significantly increased all three housekeeping genes expression over time
(Schmittgen and Zakajsek, 2000). However, when normalized for RNA content l8S
rRNA did not change while GAPDH and ~-actin increased over time exposed to serum
(Schmittgen and Zakajsek, 2000). Cultured alveolar macrophages varied more in ~-actin
expression levels than in GAPDH when exposed to various cell stimulators in culture
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over a 22 h period (Foss et al., 1999). During differentiation, cultured brown adipocytes
increased in GAPDH mRNA expression when compared to 18S rRNA over a 5 d period
with exposure to insulin increasing this effect when included in the culture (Barroso et
al., 1999). This increase in GAPDH mRNA levels due to insulin occurred in a time
dependent manner, increasing over a 20 h period (Barroso et ai, 1999). Insulin, IGF- 1
and IGF-2 in cultured adipocytes also caused a dose dependent increase in GAPDH
expression levels when exposed to each for 24 h (Barrosos et al., 1999). These findings
suggest that the experimenter must first validate a housekeeping gene as it pertains td
their experimental paradigm before using it as an internal control. For the purposes of
this thesis, 18S rRNA was chosen due to it lack of response to serum stimulation as well
as the hormones insulin, IGF-l and -2 all of which's effects were tested in culture.
Therefore, with each of the previous hormones differentially controlling the production of
protein and mRNA for a particular IGFBP, the objective of this thesis is to determine the
hormonal control of IGFBP-2, -3 and -4 mRNA expression in bovine granulosa and
theca cells.
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CHAPTERm
HORMONAL CONTROL OF INSULIN-LIKE GROWTH FACTOR BINDING-
PROTEIN mRNA EXPRESSION IN BOVINE GRANULOSA AND 1.
THECA CELLS: QUANTIFICATION BY REAL-TIME RT..PCR H
ABSTRACT
To determine if expression levels of insulin-like growth factor binding proteins
(lGFBP)-2, -3 and -4 mRNA in bovine granulosa and theca cells are affected by various
hormone treatments, granulosa and theca cells were collected from bovine ovarian
follicles, cultured for 2 days in medium containing 10% FCS, and then treated for 24 h in
serum-free medium with various hormones in a total of seven experiments. Amounts of
lGFBP-2, -3 and -4 were quantitated using fluorescent quantitative real-time RT-PCR.
Relative quantitation was done using the comparative cycle threshold eet) and all values
are expressed as fold gene expression (2-MCt) relative to the sample exhibiting the highest
Liet within a particular IGFBP and experiment. Neither IGF-] nor IGF-2 had an effect (P
> O. 10) on IGFBP-2, -3 or -4 mRNA levels in small-follicle (1-5 mm) granulosa cells,
whereas follicle-stimulating hormone (FSH) in the presence or absence of insulin
increased (P < 0.05) IGFBP-3 mRNA but did not change IGFBP-2 or -4 mRNA levels.
Luteinizing hormone (LH) in the absence of insulin also increase~ (P < 0.05) small-
follicle granulosa cell IGFBP-3 mRNA levels but had no effect on IGFBP-3 mRNA
levels in the presence of insulin. Estradiol was without effect on IGFBP-2, -3 or -4
mRNA levels in granulosa cells from small-follicles. In large-follicle (> 7.9 mm)
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granulosa cells, 100 ng/mJ of IGF-l increased (P < 0.05) IGFBP-2 mRNA levels while
100 ng/ml ofIGF-2 had no effect (P > 0.10) on IGFBP-2 -3 and -4 mRNA levels. Also
in large-follicle granulosa -cells, insulin alone increased (P < 0.05) IGFBP-2 gem
expression while LH, FSH and estradiol treatments were without any significant effect.
In theca cells, IGF-2 decreased (P < 0.05) IGFBP-2 mRNA levels, but had no effect on
IGFBP-3 or -4 mRNA expression. IGF-l did not affect (P > 0.10) theca cell IGFBP-2, -3
or -4 mRNA levels. Insulin decreased (P < 0.05) IGFBP-4 expression by theca cells. but
had no effect (P > 0.10) on thecal IGFBP-2 or -3 mRNA levels. Similarly, estradiol
decreased (P < 0.05) thecal IGFBP-3 and -4 mRNA but not IGFBP-2 mRNA levels.
These results suggest that expression of IGFBP-2, -3 and -4 mRNA by granulosa and
theca cells are differentially regulated by various honnonal stimuli, therefore possibly
modulating the amount ofbioavailable IGFs to these cells.
INTRODUCTION
A normal 21-day estrous cycle in cattle is associated with a mili u of hormonal
events, consisting of both peptide and steIOid hormones, as welJ as growth factors,
interacting to regulate ovarian follicular growth and function. Among these are insulin-
like growth factor-l (IGF-l) and IGF-2 which stimulate mitogenesis and steroidogenesis
of granulosa and theca cells through autocrine, paracrine and endocrine mechanisms (for
rev. see, Spicer and Echternkamp 1995; Adashi, 1998). In cattle, intrafollicular levels of
IGF-l and insulin-like growth factor binding protein-3 (lGFBP-3) remain relatively
constant during follicular growth, while levels ofIGFBP-2, -4 and -5 in follicular fluid
fluctuate dramatically (de al Sota et aI., 1996; Funston et aI., 1996; Stewart et aI., 1996),
indicating that the amount of bioavailable IGF-1 to the follicle is ultimately dictated by
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changes in the levels ofIGFBPs. SpecificallY,lGFBP-2 -4 and -5 are nearly absent in
dominant nonovulatory (de la Sota et al. 1996; Stewart et a1. 1996) and ovulatory !-,
(Funston et aI., 1996; Spicer et al., 2001) follicles, with high concentrations detected in
large subordinate and small follicles. Also as the nonovulatory dominant follicle i
undergoing atresia (d 10 of estrous cycle) levels ofIGFBP-2 -4 and -5 increase (Stewart
et aI., 1996).
These changes seen in intrafollicular levels ofIGFBPs are likely attributed to
hormone-induced changes in gene transcription and subsequent IGFBP production
(Rajaram et aI., 1997). For example, in cultured rat granulosa cells, follicle-stimulating
hormone (FSH) decreases IGFBP-4 protein production as well as expression of its
rnRNA (Liu et aI., 1993; Erickson et aI., 1994). In cultured porcine granulosa cells, FSH
inhibits and insulin stimulates IGFBP-2 production (Mondschein et aI., 1990; Grimes et
aI., 1992). However, in bovine granulosa cells FSH was without effect, while insulin
inhibited IGFBP-2/-5 production (Chamberlain and Spicer, 2001). Production of
IGFBP-4 by ovine thecal cells was stimulated by luteinizing hormone (LH) (Armstrong
et aI., 1996), while no effect ofLH was seen on bovine thecal cellIGFBP-4 production
(Spicer and Chamberlain, 2002). Collectively, these studies indicate that IGFBP
production by granulosa and thecal cells is hormonally regulated but the specific effect of
a given hormone is likely species dependent. However, which specific IGFBP gene
expression in bovine granulosa or theca cells is influenced by estradiol, IGF-I or -2, or
leptin has not been elucidated.
In addition to changes in IGFBP production, differences in total IGFBP proteins
in follicular fluid and culture medium may in part be attributed to differences in protease
53
activity (Rajaram et aI., 1997' Fortune et aI., 200l' Spicer et al. 200J). In cattle
follicular fluid from dominant follic es was able to cleave IGFBP-4 and IGFBP-5 and this
proteolytic activity was associated positively with levels of estradiol (Spicer et a1. 2001).
Similarly, rat granulosa cell conditioned medium cleaved radiolabelled IOFBp·5 into two
smaller molecular weight bands (Fielder et aI., 1993). Moreover, western immuno and
ligand blotting techniques can. cause confusion as to which specific IOFBF s production
is being affected, due to lack of specificity of these techniques. For example previous
work in bovine granulosa cells was not able to dissertain a large band on western ligand
blotting because it comigrated with IGFBP-2/-5 (Chamberlain and Spicer, 2001; Spicer
and Chamberlain, 2002). Thus, in some situations it is necessary to measure changes in
IGFBP mRNA levels to detennine which specific IGFBP's production may be changing
due to a specific treatment. The aim of this study was to determine the hormonal
regulation of IGFBP mRNA levels in cultured bovine granulosa and theca cells using
fluorescent real-time quantitative RT-PCR, with specific focus on th.e ffects ofestradiol,
insulin, LH, FSH leptin and IGFs.
MATERIALS AND METHODS
CELL CULTURE
The following reagents iind hormones were used for cell culture: Dulbecco
modified Eagle medium (DMEM), Ham's F-12, sodium bicarbonate, gentamicin, insulin
(bovine; 28 U/mg), trypan blue, fetal calf serum (FCS), estradiol, protease, collagenase,
hyaluronidase, and Dnase all obtained from Sigma Chemical Company (St. Louis, MO);
ovine FSH (FI913; FSH activity, 15 X NIH-FSH-S1 U/mg) and bovine LH (Ll914; LH
activity 2.0 X NIH-LH-S 1 U/mg) from Scripps Laboratories (San Diego, CA);
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recombinant mouse leptin (Pepro Tech Inc., Rocky Hill NJ) and recombinant human
IGF-l and IGF-2 from R&D Systems (Minneapolis, MN).
Ovaries from pregnant and nonpregnant dairy and beef cattle were obtain d jlt a
local abattoir, placed in saline (0.15 M NaCl) and brought back to the laboratory (<: l20
min). Granulosa cells from small (1:-5 mm) and large (> 7.9 rom) follicles were collected
by aspiration using a 20-gauge needle (38.1 nun diameter) and a 3 ml syringe as
previously described (Langhout et ai., 1991). Briefly, granulosa cells were washed two
times in serum-free medium by centrifugation at 200 x g for 5 min, and then resuspended
in serum-free media containing 1.25 mg/ml collagenase and 0.5 mg/rnl Dnase to pJ:event
clumping.
Theca cells were collected from large follicles (> 7.9 rnm) by dissection as
previously described (Stewart et aI., 1995). After removal of granulosa cells by
aspiration and scraping, the theca interna was torn into small pieces and digested for I h
at 37° C on a rocking platform. Tissue that was not completely digested after enzymatic
digestion was removed via filtration through a sterile syringe filter holder with a metal
screen (149 flm mesh; Gelman, Ann Arbor, MI). The theca cells were then washed in
serum-free medium by centrifugation at 50 x g for 5 min. Theca cells were then
resuspended in serum-free media containing of 1.25 mg/ml collagenase and 0.5 mg/ml
Dnase to prevent clumping. The percentage of viable granulosa cells from small and
large follicles and theca cells from large follicles was determined by trypan blue
exclusion method and averaged: 40.6 ± 17.7, 74.0 ± 10.7, and 94.2 ± 4.2%, respectively.
Cells were then cultured at 38° C with 95% air 5% CO2 in medium consisting of a
1:1 mixture ofDMEM and Ham's F-12 containing 0.12 mM gentamicin, 2.0 mM
S5
glutamine, and 38.5 roM sodium bicarbonate. Approximately 2.0 105 viabl cell were
placed into each well of24-well Falcon multiwell plates (No. 3047" Becton Dicldn; on,
Lincoln Park, NJ) containing 1 rol medium. During the first 48 h 0 incubation cells
were cultured in medium containing 10% FCS with a medium change at 24 h. At the
conclusion of the first 48 h of incubation, cells were then washed t~ice with 0.5 ml
serum-free medium and hormonal treatments were applied for 24 h. Media was then
aspirated from each well and 0.5 ml ofTrizol reagent (Life Technologies, Inc.,
Gaithersburg MD) was placed into one well to lyse cells and then transferred into one
replicate well such that cells from four wells from each treatment ~ithin an experiment
were combined to form two replicate samples.
EX?ERIMENTAL DESIGN
Experiment 1. was designed to determine the effects estradiol, FSH, and LH on
basal IGFBP gene expression in granulosa cells collected from small bovine follicles.
To accomplish this, cells were cultured in medium containing 100/0 FCS for 48 h and
washed twice with 0.5 ml of serum-free medium as described earlier. Cells were then
exposed for 24 h to one of the following hormonal treatments: Control (no additions),
estradiol (300 ng/ml), FSH (30 nglml), LH (30 ng/ml), FSH (30 ng/ml) + estradiol (300
ng/ml), and LH (30 ng/ml) + estradiol (300 ng/ml). After 24 h of treatment, media was
aspirated and cells lysed for RNA extraction as described earlier.
In Experiment 2, small-follicle granulosa cells were cultured in order to determine
the effect of estradiol, FSH and (or) LH in the presence of insulin on IGFBP gene
expression. Granulosa cells were cultured as described in Experiment 1 except that
during the last 24 h of culture cells were treated with one of the following six treatments:
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insulin (100 ng/ml, to all wells unless otherwise stated) insulin + low FSH (3 ng/mt),
insulin + high FSH (30 ng/ml), insulin + LH (30 ng/ml) insulin + high FSH (30 ng/rol) +
low estradiol (3 ng/ml), and insulin + high FSH (30 ng/ml) + high estradiol (300 ng/ml).
After 24 h of treatment, media was aspirated and cells lysed for RNA extraction as
described earlier. r
Experiment 3 was carried out to compare the effects ofIGF-l and -2 on IGFBP
gene expression in small-follicle granulosa cells. Granulosa cells were cultured as
described in Experiment I except that during the last 24 h of culture cells were treated
with media containing no additions (Control), 100 ng/ml ofIGF-I or 100 ng/ml ofIGF-2.
After 24 h of treatment, media was aspirated and cells lysed for RNA extraction as
described earlier.
Experiment 4 was designed to test the effects of insulin, FSH, LH, and estradiol
on expression IGFBP mRNAs in granulosa cells collected from large follicles (> 7.9
mm). Large-follicle granulosa cells were cultured as described in Experiment I except
that during the last 24 h of culture, cells were treated with: Control (no additions), insulin
(100 ng/ml, all other wells containing insulin at same concentration), insulin + FSH (30
ng/ml), insulin + LH (30 ng/ml), insulin + FSH + low estradiol (3 ng/ml), and insulin +
FSH + high estradiol (300 ng/ml). After 24 h of treatment, media was aspirated and cells
lysed for RNA extraction as described earlier.
Experiment 5 was designed similar to Experiment 3 to test the effects of IG F -1
and -2 as well as leptin and low doses ofFSH and IGF-! on moderately differentiated
large-follicle granulosa cells. Granulosa cells were cultured as described in Experiment 1
except that during the last 24 h of culture cells were treated with: Control (no additions),
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IGF-I (100 ng/ml), IGF-2 (100 ng/ml), IGF-I (3 ng/ml) FSH (3 ng/ml) or leptin (100
ng/ml). After 24 h of treatment, media was aspirated and cells lysed for RNA extraction
as described earlier
Experiment 6 was carried out to determine the effect of insulin estradiol and LH
on IGFBP gene expression in theca cells. Large-follicle theca cells were cultured in
medium containing 10% FCS for 48 h and washed twice with 0.5 ml of serum-free
medium as described earlier. Cells were then treated for 24 h with one of the following
six treatments: Control (no additions), LH (30 ng/ml), estradiol (500 ng/ml)" insulin (100
ng/ml), LH + insulin, and estradiol + insulin. After 24 h of treatment, media was
aspirated and cells lysed for RNA extraction as described earlier.
Experiment 7 was carried out to compare the effects of lOP-1 and -2 on the
expression ofIGFBPs in theca cells of large follicles. Theca cells were cultured as
described in Experiment 6 except that during the last 24 h of culture, cells were treated
with: Control (no additions), 100 ng/ml of IOF-I or 100 ng/ml of IGF-2. After 24 h of
treatment, media was aspirated and cells lysed for RNA extraction as described earlier.
mRNA ANALYSES
RNA extraction. Total cellular RNA was isolated from cultured granulosa and
theca cells by lysing them in 0.50 ml of Trizol reagent (Life Technologies, Inc.,
Gaithersurg, MD). Lysed cells were transferred to 1.5 ml eppendorf tubes and then
incubated in Trizol for 5 min at 22° C. Next, 0.10 rol of chloroform (Sigma Chemical
Co., 81. Louis, MO) was added and each sample vortexed for 15 sec. Following a 3 min
incubation at 22° C, samples were centrifuged (3500 x g) for 30 min at 4° C. The upper
aqueous phase was transferred to a new eppendorftube and RNA precipitated with 0.250
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ml of isopropyl alcohol (Pierce Chemical Company, Rockford IL). Samples were gently
mixed by hand and then incubated at 22° C for 10 min, followed by centrifugation at
3500 x g for 10 min at 4° C. The supernatant was then removed and the RNA pellet
washed with 0.50 ml of75% ethanol and then centrifuged as before for 5 min. Ethanol
supernatant was removed and RNA pellet allowed to dry for 5 min at 22 0 C. The RNA
was then dissolved in 0.030 ml ofT.E. buffer (10 mM Tris-CI, 1 mM EDTA; pH 7.4).
Quantification of total RNA was determined spectrophotometrically at the 260 nm
reading after which samples were aliquoted and stored at -800 C until used for
quantification ofIGFBP-2, -3 and -4 mRNA expression. Just prior to use, a RNA aliquot
was thawed on ice for 3-5 min.
Quantitative RT-PCR. Fluorescent real-time quantitative RT-PCR was used to
determine differences in mRNA expression levels for IGFBP-2, -3 and -4 between
treatments within bovine granulosa and theca cells in each experiment. Expression levels
were quantitated using one-step RT-PCR reaction following manufacture's specifications
with modifications for Taqrnan® Gold RT-PCR kit (PIN N808-0233; PE Biosystems,
Foster City, CA). The Taqrnan probes for each IGFBP contain a 5' reporter dye (TET)
and 3' quencher dye CTAMRA). Cleavage of this probe after annealing to the IGFBP
target of choice by 5' endogenous nuclease activity of Amplitaq Gold DNA polymerase
results in an increase in the detection of fluorescence of the reporter dy'e upon'release
from the quencher which is quantified at each PCR cycle. A total reaction volume of 25
JlI consisted of 200 nM forward primer (lGFBP-2,-3 or -4), 200 nM reverse primer
(lGFBP-2, -3 or -4), 100 nM fluorescent probe for IGFBP-3 and -4, 200 nM fluorescent
probe for IGFBP-2, 12,5 Jll of Taqman Master mix without UNG, 0.625 III Multiscribe
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and RNase inhibitor mix (PIN 4309J69, Applied Biosystems Foster City CA) and 100
ng of total RNA brought to volume with RNase free water One-step RT-PCR
amplification was performed in the ABI PRlSM® 7700 Sequence Detection System
(Applied Biosystems, Foster City, CA). Thennal cycling conditions were as follows: 30
min at 48° C for reverse transcription, 95° C for 10 min for Amplitaq Gold activations,
finishing with 40 cycles of 95° C for 15 sec for denaturing and 60° C for 1 min for
annealing and extension. Ribosomal18S RNA control kit (PIN 4308329, PE Biosystems,
Foster City, CA) was used as a housekeeping gene to normalize samnles for any variation
in RNA loading. To verify that the 18S rRNA had the ability to detect fold changes in
amounts of RNA loaded in a parallel fashion with the target probe (IGFBP-2, -3 or ~4),
decreasing amounts of total RNA were analyzed for 18S rRNA (500, 100,50,10,5, or 1
pg) or target (IGFBP-2, -3 or -4) rnRNA (500, 100, 50, 10, 5 or 1 ng) with results
illustrated in Fig. 1.
Quantification of gene expression was made by setting an arbitrary threshold on
the TET curves in the geometric portion oftbe RT-PCR amplification plot (Figure 2)
after examining the log view. Relative quantification oflGFBP-2, -3 and -4 mRNA
expression was done using the comparative threshold cycle (Ct) method (ABI SDS User
Bullentin #2). Briefly, the ~Ct was detennined by subtracting the 18S Ct from the target
unknown (IGFBP-2, -3 or -4) Ct value. For each IGFBP mRNA, the MCt was
detennined by subtracting the highest ~Ct from all other ~Ct values within each
experiment. Fold changes in mRNA expression of IGFBP-2, -3 or -4 were then
calculated as TMCt. For each mRNA species, data are expressed as fold of the lowest
treatment-group mean fold gene expression within an experiment.
"
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RT-PCR Primer and Probe Design. Primers and probes for quantitative RT-PCR
were made using Primer Express™ software (Foster City, CA) with the foUowing
manufacture's restrictions: The temperature melting (Tro) for primers was set at 50 to
60° C with the probe's Tm to be at least 100 C higher. The minimum GC bp content for
the primers and probes should be 20-80% avoiding runs of an identical nucleotide. The
minimum length of the strands should be 9 nucleotides though not to exceed 40.
The available bovin.e sequen.ces for IGFBP-2, -3 and -4 in GENBANK
(http://www.ncbi.nlm.nih.gov/entrezJquery.fcgi) were analyzed. by the Primer Express™
program to determine optimum primer and probe locations. IGFBP-2 (954 bp;
Accession AF074854) forward and reverse primers were constructed from bp 466 to 486
with a sequence of GACGGGAACGTGAACTTGATG and from bp 518 to 536 with a
sequence ofTCCTT~ATGCCGGACTTGA,respectively Cr.able 1). The probe for
IGFBP-2 was found between bp 489 to 509 and has a sequence of
AGGTGGAGGTGGTGCCGGTCG (Table 1). Forward and revet:se primers for IGFBP-
3 (1568 bp; Accession M76478) were designed from bp 1137 to 1163 with a sequence of
AAAGAGATGTTTGAAATGCCTAGTTTT, and from bp 1200 to 1224 with a sequence
ofTCAAACTCGGTTTCACTGACTACTG, respectively (Table 1). The probe for
IGFBP-3 was found between bp 1165 and 1191 has a sequence of
TTCCACATGGTGAACCTGGCATCTTC (Table I). An IGFBP-4 (2028 bp; Accession
S52770) forward primer was constructed from bp 1733 to 1757 with a nucleotide
sequence ofGAGGAAAGAATGTATGTGCCTGATG while the reverse primer was
found between bp 1808 to 1827 with a sequence ofGACCACAAACGGAGGAGGAA
(Table 1). The IGFBP-4 probe was located from bp 1772 to 1799 with the sequence of
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CATGCTGGGAGGTGAGGGACTfATCTGG (Table 1). All primers and probe met
aforementioned specifications regarding Tm and GC content set forth by the
manufacturer. A blast search (hltp:llw\ w.ncbi.nlm.nih.g '10 was al 0
conducted to assure that primers and probes had not been designed from any homologous
regions that would code for other proteins. I I
STATISTICAL ANALYSES
Data are presented as the least-squares means ± SEM. Each experiment was
replicated 3 to 4 times with different pools of granulosa and theca cells, with duplicate
samples taken from each pool. Each pool of theca cells and large-follicle granulosa cells
was o~tained from 5 to 7 follicles. Each pool of small-follicle granulosa cells was
obtained from approximately 5 to 15 ovaries. For each experiment, treatments were
applied in quadruplicate culture wells with each sample being obtained from two wells as
described earlier. Using the general linear model ofSAS (1999), treatment effects were
determined. Specifically, main effects (treatments and experimental replicates) and
interactions on dependent variables (IGFBP mRNA levels) were analyzed. Outliers were
detected and determined by an outlier determination test as described by Ott (1977).
IGFBP mRNA levels are expressed as relative mRNA abundance and specific differences
in relative mRNA abundance were determined using Fischer's protected least significant
difference test (Ott, 1977) if significant treatment effects were detected.
RESULTS
Experiment 1: Effects ofestradiol, FSH and (or) LH on small-follicle granulosa IGFBP
mRNA levels.
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Small-follicle granulosa cells had detectable amounts of mRNA for IGFBP-2 -3
and -4. Estradiol, FSH and LH treatments had no effect (P > 0.30) on IGFBP-2 Qr-4
mRNA levels in granulosa cells from small-follicles. However both FSH and LH
increased (P < 0.05) IGFBP-3 mRNA levels when compared to control values (Fig. 3B).
In contrast, estradiol had no effect (P> 0.10) on basal and FSH-induced IGFBP-3 mRNA
levels but reduced the LH-induced increase in IGFBP-3 mRNA levels s~ch that control
values and LH plus estradiol did not differ (Fig. 3B). The target Ct and boCt values for
Experiment 1 are summarized in Table 1.
Experiment 2: Effects ofestradiol, FSH, and (or) LH on small-follicle granulosa IGFBP
mRNA levels in the presence ofinsulin
As in Experiment 1, all three IGFBPs were detected by fluorescent real-time
quantitative RT-PCR in these treated cells, but no effect (P > 0.10) of estradiol, FSH and
LH on IGFBP-2 or -4 mRNA levels in small-follicle granulosa cells was detected.
However, FSH treatment at both 3 and 30 ng/ml stimulated IGFBP-3mRNA levels by 2-
to 3-fold, respectively when compared to insulin-treated controls (Fig. 4B). However,
neither LH nor estradiol (3 or 300 ng/ml) affected (P > 0.10) IGFBP-3 mRNA levels in
the presence of insulin. The target Ct and boCt values for Experiment 2 are summarized
in Table 1.
Experiment 3: Effects ofIGF-l and IGF-2 on small-follicle granulosa celllGFBP mRNA
levels
The effects of 100 ng/ml ofIGF-l and IGF-2 are shown in Figure 5. In
Experiment 3, 24-h treatment of 100 ng/ml of IGF-l had no effect (P > 0.10) on mRNA
levels forIGFBP-2, -3 or -4. Similarly, treatment with 100 ng/ml of IGF-2 for 24 h had
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no effect (P > 0.10) on IGFBP-2, -3 OF -4 mRNA levels in granulosa cells from mall-
follicles. The target Ct and .1.Ct values for Experiment 3 are summarized in Table 3.
Experiment 4: Effects o/insulin, FSH, LH and estradiol on large-follicle granulosa cell
IGFBP mRNA levels
(. IGFBP-2, -3 and -4 mRNA were all produced at detectable levels in large-follicle
granulosa cells. Insulin, estradiol, FSH and LH treatments had no effect (P > 0.25) on
IGFBP-3 or IGFBP-4 mRNA levels in large-follicle granulosa cells. In contrast,
treatment with insulin alone increased (P < 0.05) relative IGFBP-2 mRNA levels when
compared to controls (Fig. 6A). However, treatment with FSH and LH plus insulin had
no further effect (P > 0.10) on insulin-stimulated IGFBP-2 mRNA Ie els. Furthermore,
treatment with 3 or 300 nglml of estradiol along with FSH plus insulin did not affect (P >
0.10) IGFBP-2 mRNA levels when compared to treatment with FSH plus insulin alone
(Fig.6A). The target Ct and .1.Ct values for Experiment 4 are summarized in Table 2.
Experiment 5: Effects o/IGF-l, IGF-2, FSH, and leptin on relative abundance ofIGFBP
mRNA in large-follicle granulosa cells
Treatment with IGF-1, IGF-2, FSH or leptin did not affect (P > 0.10) IGFBP-3 or
-4 mRNA levels in granulosa cells from large follicles. In contrast, 100 ng/ml ofIGF-1
tended (P < 0.06) to increase IGFBP-2 mRNA levels by 2-fold above control cultures
(Fig.7A). However, treatment with 3 ng/rol ofIGF-I, FSH, leptin or 100 nglml ofIGF-2
had no effect (P> 0.10) on IGFBP-2 mRNA levels when compared to basal levels
produced by control cultures. The target Ct and 6Ct values for Experiment 5 are
summarized in Table 3.
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Experiment 6: Effects ofi ulin. estradiol, and LH on IGFBP mRNA levels in Ih ca cells
from large follicles
Theca cells from large follicles had detectable mRNA for IGFBP-2, -3 and-4.
Treatment with insulin, estradiol or LH did not affect (P > 0.10) mRNA levels for
IGFBP-2 (Fig. 8A). In contrast, significant treatment effects were observed for both
IGFBP-3 (P < 0.05) as well as IGFBP-4 (P< 0.001) (Fig. 8B and 8e). Treatment with
estradiol decreased (P < 0.05) IGFBP-3 levels in theca cells (Fig. 8B). Treatment with
estradiol plus insulin caused a similar decrease in IGFBP-3 mRNA levels as observed
with estradiol alone (Fig. 8B). Treatments with LH, LH plus insulin, Bnd insulin alone
bad no effect (P > 0.10) on IGFBP-3 mRNA levels (Fig. 8B). However,IGFBP-4
mRNA levels were decreased (P < 0.05) by treatments with insulin alone and estradiol
alone compared to control cultures; these inhibitory effects were not altered by
concomitant treatment with other honnones (Fig. 8C). Treatment with LH alone had no
effect (P > 0.10) on IGFBP-4 mRNA levels in theca cells. The target Ct and flCt values
for Experiment 6 are summarized in Table 2.
Experiment 7: Effect's ofIGF·l and IGF-2 on IGFBP mRNA levels in theca cells fro",!
large follicles
In Experiment 7, no treatment effects (P > 0.10) were detected for IGFBP-3 or -4
when treated with 100 ng/ml ofIGF-l or IGF-2 (Fig. 9). However, treatment with 100
ng/ml ofIGF-2 caused a 2.5-fold decrease (P < 0.05) in IGFBP-2 mRNA levels when
compared to contro~s. IGF-I, on the other hand, had no effect (P > 0.10) onIGFBP-2
mRNA levels in theca cells (Fig. 9). The target Ct and 6Ct values for Experiment 7 are
summarized in Table 3.
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DISCUSSION
The results of the present study revealed that: I) IGFBP-2, -3 and -4 mRNAs
were all readily detectable by fluorescent real-time quantitative RT-PCR in granulosa
cells from large and small follicles as well as theca cells from large follicles. 2) Insulin
and estradiol decreased IGFBP-4 mRNA levels, while estradiol decreased IGFBP-3
mRNA levels and IGF-2 decreased IGFBP-2 mRNA levels in theca cells. 3) Insulin and
IGF-l increased large-follicle granulosa cell IGFBP-2 mRNA levels, whereas estradiol,
LH, leptin and IGF-2 did not affect IGFBP-2, -3 or -4 mRNA levels in large-follicle
granulosa cells. 4) FSH and LH increased IGFBP-3 mRNA levels in 'Smail-follicle
granulosa cells whereas hormone treatments did not affect IGFBP-2 or -4 mRNA levels
in granulosa cells obtained from smaU follicles.
In the present study we detected mRNA for IGFBP-2, -3 and -4 in both theca and
granulosa cell cultures using fluorescent quantitative real-time RT-peR. Previously,
using RT-PCR, IGFBP-2 was predominately found in granulosa cells while IGFBP-4 was
found in thecal cell cultures, with IGFBP-3 detected in large-follicle granulosa and theca
cells in cattle (Armstrong et aI., 1998; Voge et aI., 2001). Using in situ hybridization in
bovine follicles, IGFBP-2 mRNA was primarily found to be expressed in the granulosa
cells of subordinate follicles, while IGFBP-3 was detected in only 2 of 28 follicles
examined (Yuan et aI., 1998). In healthy ovine ovarian follicles, IGFBP-2 mRNA was
found to be localized in granulosa cells, while IGFBP-4 and IGFBP-5 mRNA were
mainly expressed by thecal cells (Besnard et aI., 1996). Similarly in porcine ovaries,
I .
..
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IGFBP-2 mRNA was localized to granulosa cells and IGFBP-4 to theca -cells with low
amounts ofIOFBP-3 detected in b0th cells types (Liu et ai., 2000; Wandji et aI. 2000).
Differences in studies in localization and abundance of detected IOFBP mRNA may in
part be explained by sensitivity of the technique used, physiological status of the follicle,
and species examined.
FSH effects on fGFBP mRNA
In the present study, 24-h treatment with FSH had no effect on IGFBP-2 or
IGFBP-4 mRNA levels in granulosa cells of small and large follicles. Similarly, FSH
had no effect on IGFBP-2/5 or IGFBP-4 production by cultured bovine (Chamberlain and
Spicer, 2001), human (Cataldo et aI., 1993) or ovine (Armstrong et aI., 1996) granulosa
cells. However, in cultured bovine granulosa cells collected from medium-sized follicles
(4-8 mm) treated with 50 ng/ml ofFSH for 4 d, IGFBP-2 mRNA levels were
significantly decreased while 1 ng/mt was without effect (Armstrong et al., 1998). In the
present study, FSH-induced increases in IGFBP-3 mRNA levels in small-follicle
granulosa cells but had no effect on large-follicle granulosa cell IGFBP-3 mRNA.
Similarly, Ingman et al. (2000) reported that bovine granulosa cells associated with the
oocyte-cumulus complex in small follicles showed an increase in IGFBP-3 production in
vitro after 24 h exposure to FSH. Perhaps FSH increases local production ofIGFBP-3 in
small-follicle granulosa cells to increase local stores oflGF-l for enhanced granulosa cell
proliferation as the follicle develops. In vivo treatment with exogenous FSH in cattle had
no effect on IGFBP-3, -4 and -5 levels in follicular fluid of dominant and large estrogen-
active follicles (Echternkamp et aI., 1994; Rivera and Fortune, 2001), but either increased
IGFBP-2, levels in large estrogen-active follicles after 5 days of treatment (Echtemkamp
67
et aI., 1994) or 2 days of treatment (Rivera and Fortune 2001) r spectively. In furth r
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support of the results of the present study, Grimes et al. (1994) reported that stimulation
of porcine granulosa cells with FSH had no effect on IGFBP-4 mRNA expression. In rat
granulosa cells, a biphasic effect ofFSH on IGFBP-4 has been shown with low doses (3
ng/m)) increasing and high doses (30 and 100 ng/ml) inhibiting production (Erickson et
aI., 1994). In FSH-treated rat granulosa cell cultures, two lower molecular weight bands
(21.5 and 17.5 kDa) were detected with an IGFBP-4 antibody indicating the possibility of
an FSH-induced IGFBP-4 protease (Liu et aI., 1993). Recently, it has been suggested
that decreases in IGFBP-4 could be due in part to increased levels of pregnancy
associated plasma protein-A (PAPP-A), an IGFBP-4 specific proteas~ produced by
granulosa cells (Conover et at., 2001; Mazerbourg et a1., 2001). Thus, this data taken
together would suggest that species differences, variable dose and duration ofFSH
treatment, variation in the differentiated state of granulosa cells used, and (or) presence of
IGFBP proteases may explain the differences among studies for the response to FSH.
Insulin effects on IGFBP mRNA
In the present study, insulin increased IGFBP-2 mRNA levels in large-follicle
granulosa cells and decreased IGFBP-4 mRNA levels in thecal cells but had no effect on
IGFBP-3 mRNA levels in either cell type. Consistent with the present study, treatment of
cultured human (Greisen et a1., 2002) and porcine (Grimes and Hammond, 1992)
granulosa cells with insulin increased levels of IGFBP-2 in medium. However, in bovine
large-follicle granulosa cells, insulin decreased a band on ligand blQts that co-migrated
with IGFBP-2/-s but which specific binding protein was decreased could not be
ascertained (Spicer and Chamberlain, 2002). Interestingly, in rat hepatocytes, insulin
6inhibited IGFBP-2 production and levels of its mRNA (Schmid et al., 1992). Similar to,
the present study, insulin had no effect on IGFBP-3 production by human granulosa cells
(Cataldo et a1., 1993; Greisen et al., 2002) or bovine granulosa and theca cells
(Chamberlain and Spicer, 2001; Spicer and Chamberlain, 2002). In contrast to the .
present study, 24-h insulin treatment did not affect IGFBP-4 protein production in bovine
thecal cells (Spicer and Chamberlain, 2002). Many studies indicate that an up- or down-
regulation in rnRNA expression precede a change in detectable protein levels (LaPolt et
a1., 1990; Rosato et al., 2001; Wang et al., 2001), and may in part explain this latter
discrepancy between studies. In addition, insulin's effect on IGFBP-4 may be dose
dependent, as insulin at low doses (~ 10 ng/ml) had no effect while high doses (~ 100
ng/rnl) increased IGFBP-4 in human endometrial cells (hwin et aI., 1995). Therefore, the
effects of insulin on IGFBP production and mRNA levels may depend on cell type,
species, dose of insulin used, and duration of treatment.
IGF effects on IGFBP mRNA
I I
In the present study, levels ofIGFBP-3 and -4 mRNA in granulosa and theca cells
were not affected by IGF-l or -2. However, treatment with IOF-] tended to increase
IGFBP-2 mRNA levels in large-follicle granulosa cells, while having no effect on
IGFBP-2 mRNA levels either theca or small-follicle granulosa cells. In contrast, IGF-2
decreased IGFBP-2 mRNA levels in bovine theca cells in the present study. Similarly,
Cataldo et al. (1993) reported a 49% decrease in IGPBP-2 levels in human luteinizing
granulosa cells after treatment with lGF-2. Moderately differentiated porcine granulosa
cells had increased levels ofIGFBP-3 and IGFBP-2 as well as increased IGFBP-3 mRNA
levels after 48 h exposure to IGF-l (Grimes and Hammond, 1992; Grimes et aI., 1994).
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IGFBP-3 mRNA levels were increased to a maximum after 6 h of treatment with IGF
and remained elevated after 24 b in bovine fibroblasts (Bale and Conov r, 1992). In
further support of the present study IGFBP-3 production by bovine mall-follicle
granulosa cells did not change after 24 h treatment with IGF-l (Ingman et aI., 2000).
Perhaps the overall role ofIGFs on IOFBP production in the bovine ovary may be
negligible. Direct infusion oflGF-1 into the ovarian interstitium in cattle had no effect
on levels of IGFBPs in follicular fluid ofthe two largest foBides when compared to
animals receiving saline (Spicer et aI., 2000). In human endometrial cells, IGF-l showed
decreased levels ofIGFBP-l and IGFBP-4 with no effect on IGFBP-2 levels while IGF-
2 decreased levels ofIGFBP-l, -2 and -3 (Irwin et ai., 1995). Through a different
mechanism than FSH, IGF-I may also be decreasing levels of IOFBP-4 found in
follicular fluid through induction ofIOFBP-4 protease activity. For example, when IGF-
I was added to rat granulosa cell cultures it activated the proteolysis of radiolabelled
IGFBP-4 (Iwashitaet aI., 1998). Furthermore, additionofLR3-IGF-l, which do s not
bind IGFBP-4, did not result in cleavage ofIGFBP-4 indicating that IGF-l must bind
IGFBP-4 to expose its cleavage site to the protease (Iwashita et aI., 1998). This is further
substantiated, in that addition ofIGFBP-2 and -3, which compete with IGFBP-4 for IOF-
1, along with IOF-l to media containing IGFBP-4 and bovine follicular fluid decreased
IGFBP-4 proteolytic activity (Mazerbourg et aI., 2000): However, this affect was
removed upon addition of excess IGF-l to culture (Mazerbourg et aI., 2000) Huynh
(2000) postulates the role oflGF-l in rat myometrial IGFBP-4 production may be to
stabilize the mRNA, providing a constant source of IGFBP-4 protein, with decreasing
protein levels found in media attributed to an increase in protease activity. Thus, whether
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or not IGFs have an effect on. IGFBP mRNA levels or production may depend on many
,
factors including species, cell type, and which specific IOF receptor is presen in a
particular cell type. Also, IGF-1 may be inducing specifLc protease degradation of
IGFBP-4 by binding to IGFBP-4, thus allowing for more free IGF-l to be available to
promote further ovarian function.
Estradiol effects on IGPBP mRNA "
The present study found that estradiol had no effect on IGFBP-2 mRNA levels in
any cell type, while reducing the stimulatory effect of LH and FSH on IGFBP-3 mRNA
in small-follicle granulosa cells and decreasing mRl'NA levels ofIGFBP-3 and -4 in thecal
cells of large follicles. Consistent with our study, Mondschein et al. (1990) reported that
3-day estradiol treatment has no effect on IGFBP-2 or -3 production by porcine granulosa
cells. Also, treatment with diethylstilbestrol to hypophysectomized rats decreased
IOFBP-3 transcript levels in the theca-interstitial layer ofthe ovary (Ricciarelli et aI.,
1992). Similar to the inhibitory effect of estradiol on thecal IGFBP-3 mRNA, MCF-7
cells cultured for 96 h with 10 nM estradiol had reduced IGFBP-3 levels (25% decrease)
when compared to controls (Martin et aI., 1995). Because IGFBP-3 is the major IOFBP
present in follicular fluid of cattle and IOFBP-3 levels remain relatively constant during
follicular growth (de la Sota et aI., 1996; Funston et aI., 1996; Stewart et aI., 1996), it is
unlikely that changes in local production or expression levels will contribute extensively
to the overall amounts ofIGFBP-3 in vivo. Instead, a decrease in locally produced
IGFBP-3 may reduce the biological half-life ofIGF-l in or around the cells that are
producing IGFBP-3. Similar to IGFBP-3 mRNA levels, estradiol decreased IGFBP-4
mRNA levels in cultured theca cells of the present study. In-situ hybridization studies in
-,
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porcine follicles have shown that IGFBP-4 mRNA localization in thee,a cells is at a
minimum when estradiol levels in follicular fluid are at a maximum (Liu et aI., 2000).
Also, bovine granulosa cells from large and small follicles treated ith. estr~diol for 24 h
produced less IGFBP-4 than control cultures but produced similar amounts of IGFBP-3
(Spicer and Chamberlain, 2002)..In cultured osteoblastic cells IGFBP~4 production was
decreased by estrogen (Kudo et aI., 1995; Kassem et aI., 1996). In agreement with the
present study, estradiofhad no effect on bovine thecal cell IGFBP.2 production (Spicer
and Chamberlain, 2002). Similarly, in MCF-7 cells, neither IGFBP-2 rnRNA nor protein
levels were affected by treatment with estradiol (Kim et aI., 1991). However rats treated
with estrogens displayed increased levels of IGFBJ;>-2 mRNA abundallce in theca cells
when compared to control animals (Riccarelli et aI., 19(1). Overall, th~ effects of
estradiol on the ovary may be to stimulate growth through-inhibition of IGFBP-4 mRNA
expression and thus decreased IGFBP-4 production allowing for more bioaviable IGFs to
the dominant follicle. This is further substantiated by the fact that 1G BP-2, -4 and -5
protein levels are negatively correlated with estrogen levels in bovine antral follicles in
vivo (Stewart et aI., 1996; Austin et aI., 2001; Spicer et aI., 200 I).
LH effects on IGFBP mRNA
LH had no effect on mRNA levets for IGFBP-2 or IGFBP-4 in any cell type that
was examined in the present study. However, IGFBp·] mRNA levels were incr;eased by
LH in the absence of insulin in small-follicle granulosa cells. IGFBP-3 mRNA levels
were not influenced by LH in theca or large-follicle granulosa cells. Similar to our
present study involving IGFBP-2 mRNA levels, LH had no effect on IGFBP-2
production in rat (Erickson et al., 1995), human (Voutilainen et aI., 1996), ovine
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(Armstrong et al., 1996) or bovine (Chamberlain and Spicer 2001) th cal c II in vitro.
In human granulosa cells cultured in a polycystic ovary environment, 2-d treatment ofLH
had no effect on IGFBP-2 production (Greisen et aI., 2002). However, 3-d treatment of
10 ng/ml hCG stimulated IGFBP-2 accumulation in luteinized human granulosa cell
from normal ovaries (Giudice et aI., 1991), while 3-5 d treatment of 100 ng/ml ofhCG
decreased IGFBP-2 production in another study (Cataldo et aI., 1993). In agreement with
the present study, IGFBP-3 protein levels increased in bovine theca cells after 24 h
treatment with 100 ng/ml ofLH, however no effect ofLH was seen on granulosa cell
IGFBP-3 levels in the same study (Spicer and Chamberlain, 2002). In human thecal
cells, IGFBP-3 production was blocked by 2-d treatment with 100 ng/ml ofhCG (San
Roman and Magoffin, 1992). In ovine thecal cells, LH caused a time- and dose-
dependent increase in IGFBP-4 production with maximal production seen after 4- and 6-
days in culture with 10 ng/ml ofLH (Armstrong et al., 1996). In addition, IGFBP-4
mRN A levels in bovine thecal cells were increased by 100 ng/rol of LH after 4 day
treatment (Armstrong et aI., 1998). Similarly, in vivo a subcutaneous injection ofhCG to
PMSG primed immature rats resulted in a 3.S-fold increase in total ovarian IGFBP-4
mRNA levels 24 h post-injection (Putowski et aI., 1997). This is in contrast to the
present study where no changes were observed in either granulosa or theca cell IGFBP-4
mRN A levels after 24 h exposure to 30 ng/ml of LH. Discrepancies between this study
and others on the effects ofLH on ovarian IGFBP-2, -3 and -4 mRNA levels and
production may in part be explained by species differences, as well as differences in
culture conditions (i.e. length oftime in culture) and differences in concentrations of LH
used the latter two of which may influence whether cultured cells luteinize during
,
-
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treatment. Collectively, conditions that would cause cells to luteinize in vitro (i.e.
extended periods of high LH/hCG doses) appear to decrease granulosa cell IGFBP-2 and
increase theca cell IGFBP-4 production.
Leptin had no effect on IGFBP-2, -3 or -4 mRNA levels in bovine large-follicle
granulosa cells. This is the first evidence as to whether or not leptin is influencing
ovarian IGFBP gene expression. The lack of effect of leptin on IGFBP mRNA is
consistent with previous findings that showed no effect of leptin on IGF-i-induced
steroidogenesis of large-follicle granulosa cells (Spicer et al., 2000). Instead, leptin
inhibits insulin-induced increases in steroid production by bovine granulosa cells
(Francisco and Spicer, 1997). Overall, leptin is not affecting ovarian function in cattle
through changes in IGFBP-2, -3 or -4 mRNA expression levels
The results from the current and previous studies indicate that IGFBP gene
expression and thus production in the bovine ovary is regulated through a network of
hormonal events. In the dominant follicle with levels of lower molecular weight IGFBP
decreasing with follicular growth and increasing with atresia, IGFBP gene expression and
(or) production are likely regulated through the dynamic hormonal changes that are
occurring during a normal estrous cycle. A decrease in IGFBP gene expression and thus
decrease in IGFBP production would lead to an increase in total amount ofbioavailable
IGFs allowing for increased growth and function of the dominant follicle. An increase in
IGFBP gene expression and thus increase in IGFBP production would lead to a decrease
in bioavailable IGFs preventing or slowing follicular growth and (or) inducing atresia.
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Figure 1. Results of the test for parallelism between the housekeeping gene 188 rRNA
(+) and IGFBP-2 (~, Panel A), IGFBP-3 (0, Panel B) or IGFBP-4 (0, Panel C). Different
fold amoWlts of total RNA (1 to 500 ng for IGFBPs and 1 to 500 pg for 18S rRNA) were
added to peR reaction as described in Materials and Methods to determine if fold
changes in target could be detected in a parallel fashion.
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Figure 2. Amplification plots for amounts ofIGFBP-2, -3 and -4 mRNA and I8S rRNA
from cultured bovine granulosa and theca cells using quantitative real-time rt-PCR.
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Figure 3. Effects of FSH, LH and estradiol on IGFBP-2 (A), IGFBP-3 (B), and IGFBP-4
(C) mRNA Levels in granulosa cells of small follicles (1-5 mrn) in Experiment 1. Cells
were cultured for 48 h as described in the Materials and Methods, and then treated for 24
h in serum-free medium with: no additions (CON), 300 ng/ml of estradiol (E2), 30 ng/ml
of FSH, 30 ng/ml of LH, 30 ng/ml of FSH plus 300 ng/ml of estradiol (FSH + E2), and
30 ng/ml of LH plus 300 ng/ml of estradiol (LH +E2). Within a panel, means ± SE (n =
4-8 per mean) without a common letter differ (P < 0.05).
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Figure 4. Effects of insulin, FSH, LH and estradiol on IGFBP-2 (A), IGFBP-3 (B), and
IGFBP-4 (C) mRNA levels in granulosa cells of small follicles (1-5 mm) in Experiment
2. Cells were cultured for 48 h as described in Materials and Methods, and then treated
for 24 h in serum-free medium with 100 ng/ml of insulin (CON, in all other treatment
groups unless otherwise stated), 3 ng/ml of FSH (3 FSH), 30 ng/ml of FSH (30 FSH), 30
ng/ml of LH (LH), 3 ng/ml of estradiol (3 E2), or 300 ng/ml of estradiol (300 E2).
Within a panel, means ± SE (n = 4-8 per mean) without a common letter differ (P < 0.05).
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Figure 5. Results of the effects ofIGF-l and -2 on IGFBP-2. -3 and -4 mRNA
levels (fold change in expression within IGFBP) in small-follicle (1-5 mm)
granulosa cells of Experiment 3. Granulosa cells were cultured for 48 h as
described in Materials and Methods and then treated 24 h in serum-free medium
containing: no additions (Control). 100 ng/ml ofIGF-l or 100 ng/mt oflGF-2.
Values are means ± SE (n = 4-8 per mean). No significant differences were
detected (P > 0.10).
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Figure 6. Effects of insulin, FSH, LH and estradiol on relative changes in IGFBP-2 (A),
IGFBP-3 (B), and IGFBP-4 (C) mRNA levels in large-follicle (> 7.9 rom) granulosa cells
of Experiment 4. Cells were cultured for 24 h in serum-free medium containing one of
the following six treatments: no additions (CON), 100 ng/ml of insulin (1), 100 ng/ml of
insulin plus 30 ng/ml ofFSH (I + FSH), 100 ng/ml of insulin plus 30 ng/ml ofLH (l +
LH), 100 ng/ml of insulin plus 30 ng/ml of FSH plus 3 ng/ml of estradiol (3 E2), or 100
ng/ml of insulin plus 30 ng/ml of FSH plus 300 ng/mt of estradiol (300 E2). Within a
panel, means (n = 4-8 per mean) without a common letter differ (P < 0.05).
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Figure 7. Effects ofIGF-I, IGF-2, FSH and leptin on relative fold changes ofIGFBP-2
(A), IGFBP-3 (B), and IGFBP-4 (C) mRNA levels in granulosa cells from large-follicles
(> 7.9 mm) in Experiment 5. Cells were cultured for 48 h as described in Materials and
Methods and then treated for 24 h with: no additions (CON), 100 ng/ml ofIGF-I
(lGF-1), 100 ng/ml ofIGF-2 (lGF-2), 3 ng/mJ of FSH (FSH), 100 ng/ml of leptin (LEP),
or 3 ng/ml of IGF-I. Within a panel, means ± SE (n = 4-8 per mean) without a common
letter differ (P < 0.06).
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Figure 8. Effects of insulin, estradiol and LH on IGFBP-2 (A), IGFBP-3 (B), and
IGFBP-4 (C) mRNA levels in theca cells collected from large follicles (> 7.9 mm) in
Experiment 6, Cells were cultured for 48 h as described ,in Materials and Methods and
then treated for 24 h in erom-free medium with: no additions (CON), 100 ng/ml of
insulin (1), 500 ng/ml of estradiol (E2), 30 ng/ml ofLH (LH), 100 ng/ml of insulin plus
30 ng/ml of LH (LH + I), or 100 ng/ml of insulin plus 500 ng/ml of estradiol (E2 + I).
Within a panel means ± SE (n =4-8 per mean) without a common letter differ (P < 0.05).
! J
88
6 A
WFheca Cells
IGFB~-2
4
2(1)
u
Coco CON INS E2 E2+1 LH LH+I
"'C BC Treatments
~6 IGFBP-3
.c
CO
<4 b b
Z
C:::2
E
(1)0
, J I> CON INS E2 E2+1 lH LH+I
--+0' Treatments~8 C
(1) IGFBP-40::: 6 c c
4
2
0
CON INS E2 E2+1 lH LH+I
Treatments
89
Theca Cells
B
_ Control ~ IGF·l EZZa IGF-2
( Q)u
c:
~ 6
c:
::::I
.c
«
«z 4
D::
E
Q)
>
~ 2
Q)
D::
o
IGFBP·2 IGFBP·3
mRNA Species
IGFBP·4
Figure 9. Results of the effects ofIGF-l and IGF-2 on theca cell IGFBP-2, -3
and -4 mRNA levels (relative fold change in gene expression) from large-
follicles (> 7.9 mm) of Experiment 7. Theca cells were cultured for 48 h as
described in Materials and Methods and then treated for 24 h in serum-free
medium containing: no additions (Control), 100 ng/ml ofIGF-l or 100 ng/ml of
IGF-2. Within an IGFBP mRNA species, means ± SE (n = 4-8 per mean) without
a common letter differ (P < 0.05).
Table 1. Sequences for Primers (Forward and Reverse) and Probes for real-tim RT-
peR amplification of bovine IGFBP-2, -3 and -4.
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Gene
IGFBP-2
IGFBP-3
IGFBP-4
·Sequence
FWD Primer: gacgggaacgtgaacttgatg
REV Primer: tccttcatgccggacttga
TET Probe: aggtggaggtggtgccggtcg
FWD Primer: aaagagatgtttgaaatgcctagtttt
REV Primer: tcaaactcggtttcactgactactg
TET Probe: ttccacatggtgaacctggcatctttc
FWD Primer: gaggaaagaatgtatgtgcctgatg
REV Primer: gaccacaaacggaggaggaa
TET Probe: catgctgggaggtgagggacttatctgg
Accession No.
AF074854
M76478
S52770
Table 2. Quantitative peR analysis ofIGFBP-2, -3 and -4 mRNA expression in small-follicle granulosa cells treated with FSH,
LH, and estradiol (E2) without (Exp. 1, Con) and with (Exp. 2, Con) 100 ng/ml of insulin (I).
IGFBP-2 IGFBP-3 IGFBP-4
Treatment BP-2 Ctd 18S Ct ACt BP-3 Ctd 18S Ct ACt BP-4 Ctd 18SC ACt
Exp.l
Con 29.7 ± 0,4 22.6 ± 0.8 7.1 ± 0.1 27.5 ± 0.5 20.6 ± 0.5 6.8 ± 0.58 32,4 ± 1.1 21.2±1,4 11.2±0.9
E2 28.0 ± 0.5 21.5 ± 0.8 6.5 ± 0.7 26.3 ± 0.5 19.9 ± 0.6 6,4 ± 0.63b 31.3 ± 1.1 19.2±1.4 12.1±0.9
FSH 28.3 ± 0,4 21.6 ± 0.8 6.6 ± 0.7 25.1±0.5 20.3 ± 0.5 4.8 ± 0.5b 29.5 ± 0.9 19.2 ± 1.1 10,4 ± 0.7
LH 28.9 ± 0.5 22.6 ± 0.9 6.3 ± 0.8 26.8 ± 0.5 20.9 ±0.6 5.9±0.6b 30.3 ± 1.2 19.9 ± 1.5 10.3 ± 1.0
FSH+E2 28.8 ± 0.5 22,4 ± 0.8 6,4 ± 0.7 26,4 ± 0.5 20.3 ± 0.5 6.2 ± 0.58b 30.1 ± 1.1 19.5±1.4 1O.7±0.9
LH+E2 27,4 ± 0.6 20.7 ± 1.0 6.7 ± 0.9 26.1 ± 0.6 19.3 ± 0.6 6.8 ± 0.63b 29.7± 1.4 18.2 ± 1.8 11.5 ± 1.2
Exp.2
Con + I 25.9 ± 0.2 16.3 ± 0.2 9.6 ± 0.3 22.0 ± 0.1 16.3 ± 0.3 5.7 ± 0.38 28.0 ± 0,4 16.3 ± 0.2 11.7 ± 0,4
1+3 FSH 26.2 ± 0.2 16.5 ± 0.2 9.7 ± 0.3 21.0 ± 0.1 16.5 ± 0.2 4.5 ± 0.3bc 28.1 ± 0,4 16.5 ± 0.2 11.6 ± 0,4
I + 30 FSH 25.9 ± 0.2 16.3 ±0.2 9.5 ± 0.3 20.5 ±0.1 16.3 ± 0.3 4.1 ± 0.3c 27.2 ± 0.5 16.3 ±0.3 10.9 ± 0.5
I+LH 26.4 ± 0.2 17.2 ± 0.2 9.2 ± 0.3 22.2 ± 0.1 {7.2 ± 0.3 5.0 ±0.38b 28.8 ± 0.4 17.2 ±0.3 11.6 ± 0.4
1+3 E2 25.3 ± 0.2 16,4 ± 0.2 8.9 ±0.3 21.7±0.1 16,4 ± 0.3 5.3 ± 0.38 27.2 ± 0,4 16.4 ± OJ 10.8 ±0.4
1+ 300 E2 25.2 ± 0.2 16.5 ± 0.2 8.7 ±0.3 22.0 ± 0.1 16.9 ± 0.3 5.1 ± 0.3ab 27.6 ± 0.5 16.5 ± 0.2 1f.l ± 0.5
8bcWithin an Experiment and a specific IGFBP mRNA, ACt values without a conunon superscript differ (p < 0.05). \0
dSee Materials and Methods for treatment details and description ofCycle threshold (Ct) method. ......
Table 3. Quantitative PCR analysis of IGFBP-2, -3 and -4 mRNA expression in large-follicle granulosa (Exp. 4) and !theca
(Exp. 6) cells treated with no additions (Con), FSH, LH, insulin (I) and(or) estradiol (E2).
IGFBP-2 IGFBP-3 IGFBP-4
Treatmentd BP-2 Ctd 18S Ct 6Ct BP-3 Ctd 18S Ct ~Ct BP-4 Ctd 18S Ct ~Ct
Exp.4
Con 27.6 ± 0.3 18.8 ± 0.4 8.8 ± 0.3a 24.0 ± 0.2 17.4 ± 0.4 6.6 ± 0.3 28.9 ± 0.6 18.6 ± 0.3 10.4 ± 0.5
I 25.0 ± 0.3 17.9±0.4 7.1 ±0.3b 23.1 ±0.2 17.4 ± 0.4 5.7 ± 0.3 27.2 ± 0.6 18.0 ± 0.3 9.2 ± 0.4
I +LH 24.9 ± 0.3 17.4 ± 0.4 7.6 ±0.3b 22.6 ± 0.2 16.5 ± 0.3 6.1 ± 0.3 26.4 ± 0.6 17.4 ± 0.3 9.0 ± 0.4
I+FSH 25.1 ± 0.3 17.6±0.4 7.6 ± 0.3 b 22.2 ± 0.2 16.6 ± 0.3 5.5 ± 0.3 27.1 ± 0.6 17.5±0.2 9.5 ± 0.4
3 E2 24.4 ± 0.3 17.7±0.4 6.7 ± O.3b 22.0 ± 0.2 16.2 ± 0.4 5.8 ± 0.3 26.4 ± 0.6 17.0 ± 0.3 9.4 ± 0.5
300E2 24.7 ± 0.3 17.7±0.4 7.0 ± 0.3b 22.7 ± 0.2 16.7 ± 0.4 6.0 ± 0.3 26.7 ± 0.6 17.7±0.2 9.0 ± 0.4
Exp.6
Con 28.6 ± 0.5 18.4 ± 0.3 10.2 ± 0.4 22.9 ± 0.4 18.5 ± 0.2 4.4 ± O.3b 24.6 ±0.3 18.4 ± 0.3 6.3 ± O.3c
I 28.2 ± 0.4 17.6 ± 0.3 10.7 ± 0.4 22.3 ± 0.4 17.6 ± 0.2 4.7 ± 0.3b 24.4 ± 0.3 17.5±0.3 6.9 ± 0.3b
E2 29.1 ± 0.4 17.4 ± 0.3 11.6 ± 0.4 23.5 ± 0.4 17.6 ± 0.2 5.9 ± 0.38 26.3 ± 0.3 17.7±0.3 8.5 ± 0.38
E2 + I 28.1 ± 0.4 17.8 ± 0.3 10J ± 0.4 23.1 ±0.4 17.5 ± 0.2 5.7 ± OJa 27.4 ± 0.3 19.5 ± OJ 7.9 ± OJab
LH 29.3 ± 0.4 18.3 ± 0.3 11.0 ± 0.4 22.9 ± 0.4 18.4 ± 0.2 4.5 ± 0.3ab 24.8 ± OJ 18.5 ± OJ 6.3 ± 0.3c
LH+I 28.3 ± 0.5 17.6 ± 0.3 10.7 ± 0.4 22.3 ± 0.4 17.1 ± 0.3 5.2 ± O.3ab 26.4 ± 0.4 18.9±0.4 7.5 ± 0.3 8b
abCWithin an Experiment and a specific IGFBP mRNA, l1Ct values without a common superscript differ (P < 0.05).
dSee Materials and Methods for treatment details and description of Cycle Threshold (et) method.
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Table 4. Quantitative PCR analysis of IGFBP-2, -3 and -4 mRNA expression in small-follicle (Exp. 3), large-follicle (Exp. 5)
granulosa and theca (Exp. 7) cells treated with no additions (Con), IGF-l, IGF-2, FSH and(or) Leptin (LEP).
IGFBP-2 IGFBP-3 IGFBP-4
Treatmentf BP-2 Ctf 18S Ct ~Ct BP-3 Ctf 18S Ct ~Ct BP-4 etf 18S Ct ~Ct
Exp.3
Con 28.7 ± 0.2 20.1 ± 1.3 8.6 ± 1.4 24.7 ± 0.2 20.1 ± 1.6 4.5 ± 1.7 31.0 ± 0.3 20.1 ± 1.6 10.9 ± 1.7
IGF-l 26.3 ± 0.3 16.6 ± 1.7 9.7 ± 1.8 24.2 ± 0.2 19.2 ± 1.6 4.9 ± 1.7 29.3 ± 0.3 19.2±1.6 10.0±1.7
IGF-2 26.7 ± 0.3 19.5 ± 1.5 7.2 ± 1.6 23.8 ± 0.2 20.5 ± 1.6 3.3 ± 1.7 29.5 ± 0.3 20.5 ± 1.6 9.0± 1.7
Exp.5
Con 28.6 ± 0.3 19.2 ± 0.4 9.4 ± 0.3ab 24.8 ± 0.3 19.2 ± 0.6 5.6 ± 0.5 28.9 ± 0.7 19.1 ± 0.6 9.8 ±0.5
3IGF-I 26.9 ± 0.4 18.0 ± 0.4 8.9 ± 0.3ab 23.7 ± 0.3 17.7±0.7 6.0±0.6 27.7 ± 0.7 18.1±0.6 9.6 ± 0.5
100IGF-l 26.2 ± 0.3 17.6 ± 0.4 8.6 ± 0.3c 23.3 ± 0.3 17.6 ± 0.5 5.8 ± 0.5 27.0 ± 0.7 17.6 ± 0.6 9.5 ± 0.4
IGF-2 26.5 ± 0.4 17.7 ± 0.4 8.8 ± 0.3abc 23.9 ± 0.3 17.9 ± 0.6 6.0 ± 0.5 28.0 ± 0.8 17.8 ± 0.7 10.3 ± 0.5
FSH 27.2 ± 0.4 18.0 ± 0.4 9.8 ± 0.3a 24.3 ± 0.3 19.1 ± 0.6 5.1 ± 0.5 28.3 ± 0.7 18.9 ± 0.7 9.3 ± 0.5
LEP 27.6 ± 0.3 18.4 ± 0.4 9.2 ± 0.3ab 24.7 ± 0.3 18.9 ± 0.5 5.8 ± 0.5 29.9 ± 0.8 18.5 ± 0.7 11.4 ± 0.5
Exp.7
Con 25.9 ± 0.2 21.8 ± 0.4 4.3 ± 0.31: 23.1 ± 0.3 21.5 ± 0.4 1.6 ± 0.4 25.6 ± 0.3 21.5 ± 0.4 4.0 ± 0.4
IGF-l 23.7 ± 0.2 19.2 ± 0.3 4.6 ± O.3e 21.3 ± 0.3 19.2 ± 0.3 2.2 ± 0.3 22.8 ± 0.3 19.2±0.3 3.6 ± 0.3
IGF-2 24.5 ± 0.2 18.8 ± 0.4 5.7 ± O.3d 21.3 ± 0.3 18.8 ± 0.4 2.5 ± 0.3 23.3 ± 0.3 18.8 ± 0.4 4.5 ± 0.3
Within an Experiment and a specific IGFBP mRNA, .1Ct values without a common superscript differ abc(p < 0.06) or deep < 0.05).
fSee Materials and Methods for treatment details and description of Cycle Threshold (Ct) method. ::g
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CHAPTER IV
SUMMARY AND CONCLUSIONS
The process of where one follicle is selected to become dominant from a group of
follicles is a complex, dynamic process involving a multitude of hormonal factors.
Among these factors, IGF-l is a potent, positive stimulator of ovarian mitogenesis and
steroidogenesis. However, IGFBPs, also present within the follicle, bind IGF-l and
regulate (block) its biological activity. Because levels ofIGF-I present in the follicle in
cattle remain constant, while levels ofIGFBPs fluctuate, changing levels ofIGFBPs
within dominant growing follicles and subordinate or atretic follicles modulate the
stimulatory function ofIGF-1. The question still remains unanswered though as to the
exact mechanism(s) that manipulate the selection of one follicle to become dominant.
However, we postulate a model as illustrated in Figure 10 for the mechanisms that are
controlling the ovarian IGFBP system within the dominant follicle.
This study evaluated the effects of several hormones associated with
folliculogenesis on the up- or down-regulation ofIGFBP-2, -3 or -4 mRNA expression
levels in cultured bovine granulosa (small- and large-follicles) and theca (large follicles)
cells. IGFBP-2, -3 and -4 mRNA was detected in all cell types examined by fluorescent
real-time RT-PCR. Moreover, estradiol, LH, FSH, insulin and IGFs all influenced one or
more of the three specific IGFBP mRNA levels measured in the present study. The
hormonal effects varied depending on a particular IGFBP's mRNA as well as the cell
type examined. How all these hormones interact to controllGFBP rnRNA expression
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levels and thus synthesis was not completely elucidated. It is likely that throughout the
process of follicular development, levels of IGFBP mRNA and therefore protein
production. are being controlled by a complex network ofhormonal ev nts (some of
which may be redundant, mutually opposing ,and (or) synergesti~}as well as other factors
such as proteases to ultimately control the amount ofbioavailable IGF-l and IGF-2 to the
cell. Through a further understanding of the processes that control (ollicular
development and ultiqlately ovulation of an ovum, hopefully management techniques to
improve overall reproductive efficiency of the animal can he developed.
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Figure 10. Illustration of a proposed model for the control of the IGFBP system in the
dominant bovine ovarian follicle at or around the time of selection. The above model
postulates that the first decline seen in IOFBP-4 is more than likely controlled by an
IOFBP-4 specific protease. However, what is controlling the activation of this protease
has yet to be elucidated (possible controllers are indicated by a yellow arrow). The
decline in IGFBP-4 would then lead to an increase in free IGF-l within follicular fluid of
the follicle. The increase in free IGF-I would increase aromatase activity and thus
estradiol output by the granulosa cell layer and at the same time increasing IGFBP-2
mRNA possibly to pull free IOF-I towards the cell surface. The increase in estradiol
would then lead to a decrease in IOFBP-3 and IGFBP-4 mRNA, increasing free IGF-I as
well as IGF-2 in the thecal cell layer. IOF-2 also decreases the amount oflOFBP-2
mRNA produced by the theca layer, all leading to an increase free IGFs. The free IGFs
would then increase androgen production by the theca layer, which could then be
converted to estradiol by the granulosa cell continuing this cycle. At the same time
endocrine factors such as Insulin and LH are increasing IGFBP-2 and -5 as well as
IGFBP-3, respectively in the theca cell. This could be to pull free IGFs towards the cell
or to increase cell stores of IOF for later use. Furthermore, insulin as well as LH are
decreasing IGFBP-2/-5 production by the granulosa cell layer. However, it is possible
that this could be predominately IGFBP-5 as IOFBP-2 mRNA was upregulated by insulin
and unchanged by LH treatment.
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